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Truly, madly, deeply.  
  
  
SUMMARY 
Allergic disease is one of the most common non-communicable diseases in childhood. Both 
overweight and diet have been hypothesized to influence the risk of allergic disease. The aim 
of this thesis was to investigate the associations between overweight, fish intake and 
polyunsaturated fatty acids (PUFAs) and allergic disease throughout childhood. All analyses 
were performed on data from the Swedish prospective birth cohort BAMSE.  
 
The association between body mass index (BMI) status (as a measure of overweight) and risk 
of asthma at age 8 years was explored among 2,075 children (study I). High BMI at ages 1, 
1.5, 4 and 7 years were associated with an increased risk of asthma at age 8 years. However, 
children with high BMI during early childhood but whose BMI normalized before age 7 
years had no increased risk of asthma. In contrast, children with a high BMI at age 7 years 
had an increased risk of asthma, regardless of their earlier BMI. Moreover, a high BMI at age 
7 years was associated with an increased risk of aeroallergen sensitization at age 8 years.  
 
Fish intake in relation to subsequent allergic disease was investigated in studies II and III. A 
regular fish intake (≥2-3 times/month) at age 1 year reduced the risk of allergic disease up to 
age 12 years in analyses of 3,285 children (study II). Restriction of the analyses to children 
without early symptoms of allergic disease weakened the inverse associations with asthma 
and eczema, but the association with rhinitis was unaffected.  
 
Regular fish consumption at school age was assessed in relation to the development of IgE-
associated and non-IgE-associated rhinitis between ages 8 and 16 years in analyses of 1,590 
children (study III). For total fish intake, cod or fish fingers no significant associations were 
observed. In contrast, a regular intake of oily fish (≥1 time/week) was associated with a 
reduced risk of developing rhinitis between ages 8 and 16 years, also after adjustment for 
infant fish intake and early symptoms of allergic disease. 
 
The association between PUFAs at age 8 years and risk of allergic disease was investigated in 
studies III and IV. Calculated intake of total PUFA, α-linolenic acid (18:3 n-3), total n-6 
fatty acids, linoleic acid (18:2 n-6), and arachidonic acid (AA, 20:4 n-6) was not associated 
with rhinitis in study III. Meanwhile, higher intake of total very long-chain n-3 fatty acids 
(VLC n-3 fatty acids, the sum of eicosapentaeonic acid [20:5 n-3], docosapentaeonic acid 
[22:5 n-3], and docosahexaeonic acid [22:6 n-3]), was associated with a reduced risk of 
developing non-IgE-associated rhinitis between ages 8 and 16 years.  
 
The composition of PUFAs was measured in plasma phospholipids for a subsample of 940 
children. Increasing proportion of total VLC n-3 fatty acids was associated with a reduced 
risk of asthma, rhinitis and aeroallergen sensitization at age 16 years in study IV. In addition, 
total VLC n-3 fatty acids was associated with a reduced risk of developing asthma between 
ages 8 and 16 years. AA was associated with a reduced risk of asthma and aeroallergen 
sensitization at age 16 years. The inverse associations between total VLC n-3 fatty acids and 
AA and allergic disease were most pronounced for the IgE-associated phenotypes.      
 
In conclusion, the results in this thesis imply that modifiable factors influence the risk of 
allergic disease in childhood. Early-transient high BMI does not seem to increase the risk, 
while persistent and late high BMI seem to be associated with concurrent asthma and 
aeroallergen sensitization at school age. Moreover, fish intake, both in infancy and childhood, 
and PUFAs, especially VLC n-3 fatty acids, were associated with a reduced risk of 
subsequent allergic disease throughout childhood.  
POPULÄRVETENSKAPLIG SAMMANFATTNING 
Förekomsten av allergisk sjukdom har ökat kraftigt under de senaste årtiondena och 30-40% 
av världens befolkning är drabbad. Astma, hösnuva och eksem är exempel på allergisk 
sjukdom, många av barnen i Sverige kommer att ha minst en av dessa åkommor under 
barndomen. Två faktorer som ökar risken för allergisk sjukdom hos barn är ärftlighet och att 
utsättas för rökning under fosterstadiet eller som nyfödd. Ytterligare en mängd miljö- och 
livsstilsfaktorer, inklusive luftföroreningar, övervikt och kost, kan möjligtvis spela roll för 
risken att insjukna och intensiv forskning pågår. Förekomsten av övervikt ökade under 
samma tidsperiod som förekomsten av allergisk sjukdom. Det verkar finnas ett samband 
mellan övervikt och framförallt astma, men det är inte klarlagt om övervikt leder till ökad risk 
för astma eller tvärtom.  
 
Fisk är ett livsmedel som innehåller många olika näringsämnen. Framför allt fet fisk har ett 
högt innehåll av både vitamin D och långkedjiga omega-3 fettsyror. Dessa har visat sig ha 
egenskaper som kan påverka immunförsvaret och skulle därigenom kunna minska risken för 
allergisk sjukdom. Effekterna av omega-3 fettsyror påverkas av nivåerna av omega-6 
fettsyror som verkar ha både positiva och negativa effekter på immunförsvaret, vilket innebär 
att det är viktigt att studera dessa tillsammans. 
 
Syftet med denna avhandling var att undersöka sambanden mellan övervikt, fiskkonsumtion, 
samt omega-3 och omega-6 fettsyror och risken för allergisk sjukdom under barndomen. 
Detta gjordes med hjälp av data från födelsekohorten BAMSE, som står för ”Barn, Allergi, 
Miljö, Stockholm, en Epidemiologisk studie”, och inkluderar 4089 barn som har följts från 2 
månaders ålder upp till 16 års ålder. Kohorten är fortfarande aktiv och nästa uppföljning är 
planerad vid 22 års ålder.  
 
I den första delstudien använde vi body mass index (BMI, kg/m
2
) som ett mått på övervikt. 
Vi undersökte hur ett högt BMI vid åldrarna 1 år, 1,5 år, 4 år och 7 år, samt hur förändringen 
av BMI över tid påverkade risken för astma och allergisk sensibilisering vid 8 års ålder hos 
2075 barn. Vi såg att ett högt BMI vid åldrarna 1 år, 4 år och 7 år var kopplat till en högre 
risk för att ha astma vid 8 års ålder. När vi undersökte förändringen av BMI över tid kunde vi 
däremot se att barn som endast hade ett högt BMI vid de tidigare åldrarna och sedan 
utvecklade ett normalt BMI till 7 års ålder inte hade någon ökad risk, medan barn som hade 
ett högt BMI vid 7 års ålder hade en ökad risk för att ha astma och allergisk sensibilisering 
oavsett tidigare BMI status. 
 
I den andra delstudien undersökte vi sambandet mellan intag av fisk vid 1 års ålder och 
risken för allergisk sjukdom från 1 år upp till 12 års ålder hos 3285 barn. Vi såg en minskad 
risk för astma, hösnuva och eksem hos de barn som åt fisk minst 2-3 gånger i månaden vid 1 
års ålder. Allergiska symtom tidigt i livet kan påverka föräldrarnas benägenhet att servera 
allergena livsmedel till barnet. Eftersom vi var oroliga att sådan sjukdomsrelaterad påverkan 
  
kunde ha skett för fiskintaget vid 1 års ålder valde vi att i ett nästa steg utesluta de barn som 
haft eksem eller väsande andning innan 1 års ålder. Sambanden för astma och eksem 
påverkades av uteslutningen medan den minskade risken för hösnuva var oförändrad. 
Sambandet mellan ett regelbundet fiskintag vid 1 års ålder och hösnuva upp till 12 års ålder 
påverkades inte heller av att vi i den statistiska modellen tog hänsyn till fiskintaget vid 8 års 
ålder.   
 
I den tredje delstudien utgick vi från barn utan hösnuva vid 8 års ålder och analyserade 
sambanden mellan uppgett fiskintag samt beräknat omega-3 och omega-6 intag vid 8 års 
ålder och risken att insjukna i hösnuva mellan 8 år och 16 års ålder bland 1590 barn. Inga 
samband hittades mellan totalt fiskintag, mager fisk eller fiskpinnar och nyinsjuknande i 
hösnuva. Däremot hade de barn som åt fet fisk minst en gång i veckan vid 8 års ålder en lägre 
risk för att insjukna i hösnuva mellan 8 år och 16 års ålder. Likaså hade de barn med högst 
intag av långkedjiga omega-3 fettsyror en lägre risk för att insjukna i hösnuva. För omega-6 
fettsyror sågs inga samband.  
 
För den fjärde delstudien mättes nivåerna av fettsyror i blodprover från 940 barn vid 8 års 
ålder. Sambanden mellan blodnivåer av omega-3 och omega-6 fettsyror och risken för att ha 
eller drabbas av astma, hösnuva eller luftburen sensibilisering vid 16 års ålder undersöktes. 
Högre nivåer av långkedjiga omega-3 fettsyror minskade risken för att ha astma, hösnuva och 
luftburen sensibilisering vid 16 års ålder samt risken för att insjukna i astma mellan 8 år och 
16 års ålder. Även högre nivåer av omega-6 fettsyran arakidonsyra minskade risken för att ha 
astma och luftburen sensibilisering vid 16 års ålder.  
 
Sammanfattningsvis visar resultaten i denna avhandling att förändringsbara livsstilsfaktorer 
kan påverka risken för att ha eller insjukna i allergisk sjukdom under barndomen. Resultaten 
för BMI visar att det är viktigt att motverka fortsatt övervikt efter småbarnsåren. Att 
fiskkonsumtion både tidigt i livet och senare under barndomen verkar minska risken för 
allergisk sjukdom visar vikten av en god kosthållning och stödjer de befintliga kostråden om 
ett regelbundet fiskintag som inkluderar både mager och fet fisk.  
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1 INTRODUCTION 
Allergic disease affects 30-40% of the population worldwide.
1
 The prevalence of allergic 
disease in childhood has increased rapidly during the last decades,
2-5
 and has become one of 
the most common non-communicable diseases in childhood affecting 25% of the children in 
Europe.
1
    
 
Genetic predisposition explains part of the risk for allergic disease. Nevertheless, the rapid 
increase in prevalence implies that other factors also play a role; the environment and lifestyle 
must influence the risk of allergic disease as well. Overweight is one modifiable factor that 
has been proposed to affect the risk of asthma in particular. There has been a dramatic 
increase in the prevalence of overweight during the last decades, coincidental with the 
increase in allergic disease. Uncertainties remain as to whether overweight causes asthma or 
if it is the other way around. 
 
Diet is another modifiable factor hypothesized to affect the risk of allergic disease. There has 
been a shift in dietary intake from high consumption of butter and fish to high consumption 
of margarines and vegetable oils.
6
 This shift has led to lower consumption of saturated and 
very long-chain n-3 polyunsaturated fatty acids and to higher consumption of n-6 
polyunsaturated fatty acids. Very long-chain n-3 and n-6 polyunsaturated fatty acids are 
found to have immuno-modulatory effects and might affect the risk of allergic disease in 
opposite directions, with a protective effect of n-3 polyunsaturated fatty acids and an adverse 
impact of n-6 polyunsaturated fatty acids.
7
  
 
The aim of this thesis was to study the influence of overweight, fish intake and n-3 and n-6 
polyunsaturated fatty acids on the risk of allergic disease throughout childhood.   
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2 BACKGROUND 
2.1 CHILDHOOD ALLERGIC DISEASE 
Allergic disease is characterized by an overreaction of the immune system to a foreign 
substance, harmless for most people. Allergic diseases, such as asthma, rhinitis and eczema 
may be triggered by allergens. The process has two steps. In the first step, the person 
encounters an allergen which is taken up by antigen-presenting cells (Figure 2.1). This will, 
through multiple actions, stimulate B-cells to produce allergen-specific immunoglobulin E 
(IgE) antibodies. The allergen-specific IgE antibodies will then be released and bind to IgE 
receptors on mast cells and basophils, the person becomes sensitized.
8
 In the next step, when 
the person is exposed to the same allergen again, the specific IgE antibodies recognize the 
allergen, which leads to the release of inflammatory mediators and an allergic reaction. 
Common allergens are proteins in food and pollens, house dust mite and dander from 
animals. In addition to IgE-mediated allergic disease, children can also suffer from non-IgE-
mediated allergic disease. The triggers of this phenotype are less known. 
 
 
Figure 2.1 A simplified overview of the sensitization process and allergic reaction. A person encounters an 
allergen, which passes the epithelial barrier and is taken up by an antigen-presenting cell (APC) (1). The APC 
with the allergen will, through multiple actions, stimulate B-cells in the lymph node to produce allergen-specific 
immunoglobulin E (IgE) antibodies (2). The allergen-specific IgE antibodies are released and bind to IgE-
receptors on mast cells; the person becomes sensitized (3).  The next time a person encounters the same 
allergen it will be recognized by the allergen-specific IgE on the mast cell; this will lead to release of 
inflammatory mediators, such as histamine, and an allergic reaction (4).  
 
A child with allergic disease often suffers from more than one of these entities during 
childhood and multi-morbidity is common.
9
 A concept often mentioned is the “allergic 
march”. This concept refers to the natural sequence of allergic disease, with eczema as the 
starting point in infancy and early childhood, and later on asthma and rhinitis are developed.
10
 
 4 
2.1.1 Definition and diagnosis 
2.1.1.1 Asthma 
Asthma is a disease of the airways. It is often triggered by IgE-sensitization, but frequently 
evolves to chronic airway inflammation unrelated to allergen contact.
11
 Symptoms of asthma 
are dyspnea, wheezing, raspy breathing and coughing. Clinically, asthma is often diagnosed 
through the clinical history. In epidemiological studies, questionnaires are often used. A 
doctor’s-diagnosis is often asked for and in combination with questions on symptoms and use 
of medication it is possible to define previous and current disease. In toddlers, it may be 
troublesome to define asthma, since they often suffer from upper respiratory tract infections 
with similar symptoms.   
2.1.1.2 Rhinitis 
Rhinitis is characterized by inflammation in the nose leading to nasal blockage, sneezing and 
a runny, itchy nose.
12
 In the clinic, rhinitis is diagnosed by symptom history combined with 
an examination of the nose. In epidemiological studies, symptom questionnaires are used. 
Questions can cover symptoms following contact with allergens such as furred pets and 
pollens, and also in which season of the year the symptoms have occurred and for how long.  
2.1.1.3 Eczema 
Eczema is an inflammatory disease of the skin; the skin barrier is disrupted and this leads to 
dry skin and itchy rashes.
13
 Eczema can be diagnosed by ocular inspection. In 
epidemiological studies, questionnaires regarding symptoms, ointment usage and possible 
doctor’s diagnosis are usually used to define eczema.  
2.1.1.4 Allergic sensitization    
Occurrence of IgE antibodies in the blood shows if a person is sensitized. A person can be 
sensitized to different allergens, e.g., from foods, furred animals or pollens. Sensitization is 
clinically tested by skin prick test or by measuring the level of IgE antibodies in the blood. 
Single allergens or a mix of allergens can be tested. Phadiatop
®
 is such a mix, which contains 
antibodies of furred pets, pollens, mold and mite, while the mix fx5
®
 contains antibodies to 
the 6 most common food allergen extracts. Being sensitized does not mean that a person may 
experience allergic symptoms at exposure, but the higher the IgE level, the higher the 
likelihood of symptoms.  
 
2.1.2 Occurrence 
The prevalence of allergic disease in childhood has risen during the last decades.
3, 4
 In the 
large international multi-center study ISAAC phase III an increase in the prevalence of 
allergic disease over a 10 year period from the early 1990s to the beginning of the 21
st
 
century was observed.
3
 A British study, which assessed the prevalence of allergic disease 
among children repeatedly during 40 years until 2004, observed a steady increase from the 
 5 
 
middle of the 1960s until the end of the 1990s.
4
 After the 1990s the increase in prevalence of 
asthma seems to have leveled off, while a continued rise was observed for rhinitis and 
eczema. In the first phase of the ISAAC study large differences in prevalence of allergic 
disease were observed between regions.
14
 Although regional differences exist, 30-40% of the 
global population is affected by allergic disease, according to the World Allergy 
Organization,
1
 and asthma is the most common chronic disease among children according to 
the World Health Organization (WHO).
15
  
 
In Sweden, the pattern of change has been similar to the changes observed worldwide. The 
prevalence of childhood allergic disease in Sweden doubled between the late 70s and the 
early 90s.
2
 Since then the prevalence seems to be stable,
3, 5
 or there might be a continued 
increase in the prevalence of rhinitis among both school-aged children and adolescents.
16, 17
  
The prevalence of asthma in school-aged children was reported to be between 6-10% in the 
21
st
 century, while the prevalence rates of rhinitis and eczema seem to be around 7-15%, and 
19-26%, respectively.
3, 5, 16
 Even higher prevalence of rhinitis, in particular, has been reported 
in adolescents (26% vs. 7-15% at earlier ages).
17
  
 
2.1.3 Consequences 
The consequences of childhood allergic disease occur both on individual and societal level. 
First, on the individual level allergic disease can lead to sleep disturbance, impaired quality of 
life and absence from school.
1, 11, 18, 19
 For children with rhinitis, 2 million school-days are lost 
annually in the United States alone, according to the World Allergy Organization.
1
   
 
Second, on the societal level, allergic disease has direct and indirect effects on the economy.
20
 
Direct costs are due to the need for visits to a physician, laboratory tests and medication, 
while indirect costs depend on absenteeism from school and, for parents, from workplaces.   
 
It is important to try to prevent and manage childhood allergic disease because, in addition to 
the burden on the child, many children seem to retain with their disease into adulthood and 
suffer from it throughout life.
21
 
 
2.1.4 Risk and protective factors 
Some of the proposed risk and protective factors are covered briefly in this section. The 
topics of childhood overweight, fish, and polyunsaturated fatty acids (PUFAs) are described 
separately in later sections.  
 
Parental allergic disease has been established to increase the risk of allergic disease in 
children.
22, 23
  In addition, specific genes have been found to influence the risk of asthma, 
rhinitis and eczema, respectively.
24
 Sex has been suggested to influence the risk of allergic 
disease. Asthma is more common among boys than girls at younger ages, while there is a 
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shift to a higher prevalence among girls than boys during adolescence.
25
 Rhinitis increases 
with age in both sexes until adolescence, then the increase continue in girls but not in boys.
26
 
The changes in occurrence of asthma and rhinitis during adolescence have been proposed to 
depend on puberty and hormonal changes. In contrast, eczema is most common among girls 
throughout the childhood years.
27
 Second hand tobacco smoke exposure, often assessed as 
maternal smoking during pregnancy or parental smoking in infancy, has consistently been 
associated with an increased risk of allergic disease during childhood.
22, 28-30
 In addition, 
preterm birth has been associated with an increased risk of asthma.
22, 30
  
 
Maternal characteristics during pregnancy, such as overweight or obesity, and diet, have been 
hypothesized to influence the offspring’s risk of developing allergic disease. Maternal 
overweight or obesity might increase the offspring’s risk of asthma especially.22, 31 However, 
some of the association might be explained by the child’s own overweight.31 Childhood 
overweight in relation to allergic disease is described further in sections 2.2.3 and 2.2.4. In a 
recent meta-analysis of maternal dietary intake during pregnancy, inverse associations 
between vitamin E and zinc, and also vitamin D, and wheeze in offspring were identified; 
however, there were no consistent findings for maternal consumption of fruit, vegetables and 
other foods.
32
 In another recent meta-analysis of observational studies and randomized 
controlled trials, the conclusion was that maternal fish consumption and supplementation 
with very long-chain n-3 (VLC n-3) fatty acids during pregnancy have a suggestive influence 
on a reduced risk of allergic disease within the first 12 months of the child’s life.33 In 
addition, in a long-term follow-up of a randomized controlled trial a reduced risk of asthma in 
the group of adult offspring to mothers supplemented with VLC n-3 fatty acids compared 
with offspring to mothers supplemented with olive oil was observed.
34
 In contrast, in a 
Cochrane review the conclusion was that there was limited evidence to introduce maternal 
supplementation during pregnancy to reduce the risk of allergic disease in offspring.
35
 No 
consistent evidence for an association between maternal consumption of fish and n-3 fatty 
acids during pregnancy and reduced risk of allergic disease in offspring was reported in 
another recent meta-analysis of maternal diet during pregnancy.
32
  
 
Breastfeeding has also been hypothesized to influence the risk of allergic disease in offspring, 
however, results from epidemiological studies on breastfeeding duration have been 
conflicting.
36
 The timing of introduction of solid allergenic foods to the infant’s diet, for 
example, egg, peanut, fish, and cow’s milk, has been thought to play a role for the risk of 
allergic disease for a long time. The earlier belief was to delay the introduction of allergenic 
foods to reduce the risk of allergic disease.
37
 However, this strategy was unsuccessful and the 
focus shifted to oral tolerance and early introduction.
38
 Results from recent interventions on 
early introduction of peanuts have prompted an increased interest in this research field.
39
  
 
Already in 1989, Strachan suggested that better hygiene with fewer infections in early 
childhood was a possible explanation for the observed increase in allergic disease.
40
 
However, infections in early childhood have been observed to increase the risk.
41
 The 
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hypothesis has later been reformulated; a decreased exposure to a diversity of environmental 
microbes might lie behind the increased prevalence of allergic disease.
42, 43
 Factors that have 
been studied, related to this hypothesis, are number of siblings, living on a farm, day care 
attendance, pet ownership, and socioeconomic status. The gut microbiome might also play a 
role for the risk of childhood allergic disease; lower microbiota diversity in infancy has been 
associated with development of allergic disease.
44
 Furthermore, supplementation with 
probiotics seems to reduce the risk of eczema, but the evidence is more inconclusive for other 
allergic diseases.
44
  
  
Traffic-related air pollution might increase the risk of childhood asthma.
22, 45, 46
 In two recent 
meta-analyses the conclusion was that early exposure to traffic-related air pollution seems to 
increase the risk of developing asthma during childhood; the magnitude of the association 
increased with increasing age.
45, 46
 Exposure to mold or fungi in the indoor environment 
might increase the risk of childhood asthma.
22
 Findings for other allergic diseases are more 
inconsistent. 
 
These are some of the factors proposed to influence the risk of allergic disease in childhood. 
Most of them are related to the environment or lifestyle and potentially modifiable, 
suggesting that there are ways to decrease the risk. Some of the factors are more established 
than others, such as parental allergic disease, genetic predisposition, exposure to second hand 
tobacco smoke and prematurity.
22
  
 
2.2 CHILDHOOD OVERWEIGHT 
2.2.1 Definition and measurements 
Overweight is defined as excess of body fat to an extent that affects health.
47, 48
 An imbalance 
in energy intake and expenditure that leads to a positive energy balance results in 
accumulation of body fat. 
 
A widely used tool to define overweight in epidemiological studies is body mass index 
(BMI). BMI is calculated as weight in kilograms divided by height in meters squared (kg/m
2
). 
BMI is easy to use and has been shown to identify overweight in children to a high extent.
49, 
50
 To identify overweight in children with BMI different reference values can be used.
51
 The 
International Obesity Task Force (IOTF) constructed reference values for children 
corresponding to the adult cut offs for overweight and obesity.
52, 53
 WHO has constructed 
international BMI-for-age growth charts for children.
54, 55
 In addition, many countries have 
their own national BMI-for-age growth charts based on the child population, often using the 
85
th
 percentile as cut off for overweight and the 95
th
 percentile as cut off for obesity.
51
 In 
epidemiological studies, another method is to use the 85
th
 and 95
th
 percentile based on the 
children in a cohort. The observed prevalence can differ depending on the reference choice, 
therefore it is important to state chosen reference methods and cut offs used.      
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2.2.2 Occurrence 
In 2014, there were around 41 million preschool aged children who were overweight or obese 
worldwide, according to the WHO.
56
 The prevalence of overweight has risen dramatically in 
the most recent decades. 
 
In a study based on children below 10 years of age from eight European countries, taking 
place 2007-2010, an overweight prevalence (defined by the IOTF reference values) above 
40% in southern Europe compared with less than 10% in northern Europe, including Sweden, 
was observed.
57
 Among 10-11 year old children in Sweden, the observed prevalence of 
overweight (defined by the IOTF reference values) was higher (17-24% vs. 10% in younger 
children), but might have reached a plateau.
58
 However, the prevalence can differ widely 
depending on socio-economic status, as seen both in Europe and in Sweden; population 
groups with lower socio-economy have higher prevalence rates of overweight and obesity in 
general.
57, 58
   
 
2.2.3 Mechanisms linking overweight and allergic disease 
The concurrent epidemic of asthma and overweight led to theories about an association 
between them. Observed associations between overweight and asthma might be due to over-
diagnosis of asthma among overweight subjects. However, a number of possible mechanisms 
to explain how overweight might cause asthma have been put forward (Table 2.1).
59, 60
 Some 
of the suggested mechanisms can also explain a possible link between overweight and 
allergic sensitization. It has also been proposed that overweight and asthma might be 
determined by common genetics and lifestyle factors.
61
 Examples of shared lifestyle factors 
that have been suggested are prenatal exposures, e.g., maternal intake of antioxidants and n-3 
and n-6 fatty acids, the child’s own intake of n-3 and n-6 fatty acids, the microbiota, and 
sedentary behaviors.  
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Table 2.1 Hypothesized mechanisms suggested to explain how overweight  might cause asthma
59, 60
 
Mechanisms suggested: Examples: 
Systemic inflammation caused by fat mass-derived 
molecules 
Leptin and cytokines (TNF-alpha & IL-6 etc.)  released 
from fat mass into the blood leads to inflammatory 
activation at other sites, for example the lungs.  
Adiponectin, which has anti-inflammatory effects, 
declines in obesity 
Systemic inflammation caused by obesity-related 
oxidative stress 
Oxidative stress might cause airway oxidative stress 
and inflammation leading to asthma 
Obesity co-morbidities GERD
1
, Type-2 diabetes trough insulin resistance 
Obesity effects on lung mechanics Low tidal volume caused by obesity leads to small 
ASM
2
 strain, which gives greater stiffness in ASM, 
leading to even less ASM strain -  a bad downward 
spiral resulting in substantial ASM contraction and 
airway narrowing 
1. GERD=Gastroesophageal reflux disease 
2. ASM=Airway smooth muscle 
 
2.2.4 Observational studies of overweight and allergic disease 
One cross-sectional study, using self-reported weight and height, did not observe an 
association between BMI, used as a proxy for overweight, and asthma.
62
 A few cross-
sectional studies did not observe an association with asthma but with wheeze,
63
 or exercise-
induced respiratory symptoms.
64
 Most cross-sectional studies have observed an association 
between a high BMI, and asthma in childhood.
65-71
 However, it is impossible to draw any 
conclusions about temporal relationships from cross-sectional studies. The longitudinal 
studies performed observed a high BMI to be associated with an increased risk of asthma.
72-78
 
Some of these investigated increase in BMI over time and observed an increased risk of 
asthma.
73, 74, 77
 None of these studies have been able to assess BMI repeatedly from early 
childhood until end of follow-up and changes besides increase in BMI have not been 
investigated. Only one study examined change in BMI status and the risk of asthma in 
children and observed no association between an early-transient high BMI and asthma later in 
childhood, on the other hand, current high BMI was associated with an increased risk of 
coincident asthma.
79
 These results indicated that the pattern of change in overweight status is 
of importance to disentangle the association between overweight and asthma. A potential 
association between a high BMI and allergic sensitization was investigated in cross-sectional 
analyses with inconclusive results.
63, 64, 66, 69, 80, 81
 In two longitudinal studies, no association 
between a high BMI and subsequent allergic sensitization was observed.
78, 79
 The association 
between overweight and asthma and allergic sensitization needed further investigation in 
longitudinal studies with repeated measurement of overweight starting in early childhood.  
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2.3 DIETARY INTAKE 
“Let food be thy medicine and medicine be thy food”-Hippocrates 
Everyone has to eat. What you eat and how you eat affects many parts of your life. All the 
way back to ancient Greece, people have been interested in diet and have thought that it 
affects your health. The ancient Greeks believed that you could avoid becoming sick or get 
better by eating healthy. Today, we have national dietary recommendations that are supposed 
to reduce the risk of disease in the population, and there are different hypotheses relating diet 
to allergic disease. Two parallel hypotheses, with a focus on antioxidants and fat quality, 
were suggested during the 1990s.
6, 82
 Both hypotheses rose from an observed change in 
consumption during the preceding decades, coincident with the rise in allergic disease. In 
addition, both hypotheses have been studied during different developmental phases; in 
pregnancy, infancy and childhood. Seaton et al. suggested that a decline in fruit and vegetable 
intake lowered people’s antioxidant status, leading to a population more susceptible to the 
oxidative load from various exposures, resulting in airway inflammation.
82
 The evidence 
from observational studies with a focus on children’s own intake of antioxidants or 
antioxidant-rich foods has been inconclusive.
22, 83
   
 
The hypothesis regarding fat quality was suggested by Black and Sharp.
6
 A decreased 
consumption of butter and fish and an increased consumption of margarines have led to 
reduced amounts of saturated fat and n-3 PUFAs and an increased amount of n-6 PUFAs in 
the diet; these changes were suggested to be the reasons for the rise in asthma and allergy.
6
  
 
2.3.1 Fish intake 
2.3.1.1 Background 
In the Nordic Nutrition Recommendations, an increased consumption of fish is encouraged to 
promote energy balance and health.
84
 The Swedish National Food Agency recommends 
consumption of fish at least 2 times per week with inclusion of both lean and oily fish.
85
 Lean 
types are for example cod, pollock, and pike, while salmon, herring, and mackerel are 
examples of oily fish. The advices regarding introduction of fish into the infant’s diet have 
changed over the years. Previously, the advice was to delay the introduction of fish for infants 
at increased risk of allergic disease, however, the avoidance was not effective and the 
recommendation has been removed. Fish is a good source of several nutrients, and especially 
oily fish contain high levels of VLC n-3 fatty acids, which are hard to obtain in sufficient 
amounts from other dietary items. However, it is important to recognize that oily fish, in 
particular, can contain high amounts of dioxins and polychlorinated biphenyls, depending on 
where the fish has been caught. Therefore, children and fertile women are advised to avoid 
wild-caught oily fish from certain areas. Another aspect in choice of fish is to choose species 
not threatened by over-fishing and which are caught or farmed in an environmentally-friendly 
way. These aspects will not be discussed further in this thesis.  
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2.3.1.2 Nutritional content 
Nutrients in fish that might influence the risk of allergic disease are selenium, vitamin D and 
VLC n-3 fatty acids.  
 
Selenium seems to have both antioxidative and immuno-modulatory properties and has been 
suggested to decrease the risk of allergic disease in childhood.
86
 However, the evidence from 
epidemiological and intervention studies has not been convincing.
87-89
  
 
Vitamin D has been shown to affect the immune system in several ways.
90
 Studies on the 
association between vitamin D status and asthma have been inconclusive.
91-94
 Few studies 
have investigated a potential association between vitamin D and rhinitis; one study found an 
inverse association between vitamin D status in childhood and subsequent rhinitis.
92
 
 
VLC n-3 fatty acids eicosapentaeonic acid (EPA, 20:5 n-3), docosapentaeonic acid (DPA, 
22:5 n-3) and docosahexaeonic acid (DHA, 22:6 n-3) are present in high amounts in oily fish 
and have been hypothesized to decrease the risk of allergic disease (see more below). 
2.3.1.3 Observational studies of fish intake in childhood and allergic disease 
Introduction and consumption of fish in infancy have consistently been associated with a 
reduced risk of allergic disease in preschool ages.
95-102
 However, there have been no 
longitudinal studies which had investigated a potential association beyond preschool age.  
 
Childhood fish intake was associated with allergic disease in a number of cross-sectional 
studies,
103-112
 with some exceptions.
113-117
 None of these studies found inverse associations 
specifically for rhinitis.
104, 107, 113, 115, 116
 One longitudinal study has been performed, focusing 
on the risk of asthma and allergic sensitization, and found no association between fish intake 
during childhood and the outcomes up to age 8 years.
118
 Few of the previous studies have 
distinguished between types of fish, which is of importance if we believe that the biological 
mechanism is mediated through vitamin D or VLC n-3 fatty acids abundant in oily fish. 
There was clearly a need for longitudinal studies distinguishing between types of fish.  
 
2.3.2 Polyunsaturated fatty acids 
2.3.2.1 n-3 and n-6 families 
The n-3 and n-6 families of PUFAs are characterized by the location of their first double 
bond in the methyl chain. The n-3 family has the first double bond three carbon atoms from 
the methyl end of the carbon chain and the n-6 family has the first double bond six carbon 
atoms from the methyl end. N-3 and n-6 fatty acids are involved in many necessary processes 
in the body.
119
 N-3 and n-6 fatty acids are often present in the same foods, but n-6 fatty acids 
are often present in a higher amount. It has been hypothesized that an elevated intake ratio of 
n-6 to n-3 fatty acids might increase the risk of cardiovascular and inflammatory diseases.
120
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The n-3 fatty acid α-linolenic acid (ALA, 18:3 n-3) and the n-6 fatty acid linoleic acid (LA, 
18:2 n-6) are essential to humans as we cannot synthesize them. The main dietary sources of 
ALA are vegetable oils, like canola oil, margarines of canola oil, and walnuts. LA is found in 
vegetable oils, like sunflower, canola, and corn oils, and margarines of these oils. ALA and 
LA are medium-chain fatty acids and can be elongated to longer fatty acids in the body. 
Arachidonic acid (AA, 20:4 n-6) is the most common very long-chain n-6 fatty acid and is 
synthesized from LA in a competing pathway to the VLC n-3 fatty acids (Figure 2.2). The 
most common VLC n-3 fatty acids are EPA and DHA; these are elongated from ALA to 
some extent (Figure 2.2). The conversion both of VLC n-3 fatty acids from ALA
121
 and of 
AA from LA might be low in humans.
122
 The main dietary source of VLC n-3 fatty acids is 
oily fish, while AA is found in eggs and most types of meat.  
 
Blood composition of the essential fatty acids ALA and LA, as well as of EPA and DHA, are 
considered to be good biomarkers of dietary intake.  
 
Figure 2.2 Schematic picture of the endogenous pathways of arachidonic acid (AA, 20:4 n-6) from linoleic acid 
(LA, 18:2 n-6), and of eicosapentaeonic acid (EPA, 20:5 n-3) docosapentaeonic acid (DPA, 22:5 n-3) and 
docosahexaeonic acid (DHA, 22:6 n-3) from α-linolenic acid (ALA, 18:3, n-3). The two pathways compete for the 
same desaturases.  
2.3.2.2 The influence of very long-chain polyunsaturated fatty acids on allergic disease 
VLC n-3 fatty acids have been shown to have anti-inflammatory and inflammatory reducing 
effects, while AA is the substrate of pro-inflammatory mediators (Figure 2.3).
7, 123
 They 
appear to have an influence through incorporation into membrane phospholipids of cells 
involved in inflammation, like lymphocytes, macrophages and neutrophils.
124
 AA was 
thought of as a pro-inflammatory agent, but has been shown to have anti-inflammatory 
effects as well (Figure 2.3). Both VLC n-3 fatty acids and AA have pleiotropic effects which 
might influence the risk of allergic disease and which have not all been fully elucidated. 
Moreover, the effects of n-3 and n-6 fatty acids might be dependent on gene-nutrient 
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interactions. Genetic variations affect how the PUFAs are metabolized endogenously; this 
can potentially modulate the influence of these fatty acids on the risk of allergic disease.
125
 A 
few intervention studies with supplementation of VLC n-3 fatty acids to infants have been 
conducted. The conclusion from these was that despite increases in blood proportions of VLC 
n-3 fatty acids and possible immunological changes in the blood, no clear evidence of a 
clinical impact could be proven.
126
  
 
Figure 2.3 Arachidonic acid (AA, 20:4 n-6) and VLC n-3 fatty acids are the substrates for many different 
inflammatory (red boxes), and anti-inflammatory (blue boxes) mediators. Most effects are not yet fully 
elucidated. 
2.3.2.3 Observational studies of polyunsaturated fatty acids in childhood and allergic 
disease 
There have mainly been cross-sectional studies of the association between PUFA intake and 
PUFA proportions measured in blood, used as biomarkers of dietary intake and metabolism, 
and allergic disease in childhood. Studies of calculated dietary intake of n-3 and n-6 PUFAs 
have not observed a consistent association with allergic disease.
117, 127-129
 In contrast, some 
studies, which used blood proportions of PUFAs, observed a lower level of VLC n-3 fatty 
acids in subjects with allergic disease than in subjects without allergic disease.
104, 130, 131
  
However, there have been reports of no differences in blood proportions as well.
112
 No 
prospective studies of the influence of total PUFA and specific PUFAs on subsequent allergic 
disease up to adolescence had been performed in a population-based cohort.
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3 AIM  
The overall aim of the project was to evaluate the associations between overweight, fish 
intake, n-3 and n-6 polyunsaturated fatty acids and allergic disease throughout childhood. 
More specifically, we aimed to: 
 Examine the associations between body mass index, as a measure of overweight,  
during the first 7 years of life, and asthma and allergic sensitization at 8 years of age. 
(Study I) 
 
 Investigate the impact of fish consumption in infancy and childhood on prevalent and 
incident allergic disease up to adolescence. (Studies II and III) 
 
 Investigate the role of n-3 and n-6 polyunsaturated fatty acids, as calculated intake 
and as biomarkers in plasma, in relation to prevalent and incident allergic disease up 
to adolescence. (Studies III and IV)  
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4 RESEARCH APPROACH 
4.1 SUBJECTS 
All studies in this thesis are performed with data from the population-based birth cohort 
“Barn, Allergi, Miljö, Stockholm, en Epidemiologisk studie” (BAMSE, in English: 
“Children, Allergy, Milieu, Stockholm, an Epidemiological study”). The primary aim of 
BAMSE was to study risk factors for allergic disease, such as environmental factors, parental 
allergic disease, and diet. Newborn babies were recruited through child health centers in four 
regions in Stockholm County between February 1994 and November 1996 (Figure 4.1). The 
four regions were supposed to reflect both inner city and suburban areas, and catch a 
socioeconomic gradient.  
 
 
Figure 4.1 A map of the catchment area for the BAMSE cohort. Newborn babies were recruited from four 
regions in Stockholm County, the regions were supposed to reflect inner city and suburban areas, and to catch 
a socioeconomic gradient. 
 
During the time period in question, 7,221 children were born in the catchment area, of whom 
5,488 were eligible for inclusion in the cohort. The rest could never be reached or were 
excluded. Reasons for exclusion were that the family planned to move within a year, that the 
family had a seriously ill child or insufficient knowledge of the Swedish language, or that an 
older sibling was already enrolled. The parents of 4,089 newborns answered the first mailed 
questionnaire, when their children were a mean age of 2 months. The cohort of 4,089 children 
has been followed with repeated questionnaires and clinical examinations over the years 
(Figure 4.2). The next-follow up is under planning and will take place when the participants 
are 22 years of age. BAMSE is a closed prospective cohort, meaning that no new children 
have been included over time. The families have had the possibility to skip a follow-up and 
still be contacted for the next, as long as they did not decline further participation. Response 
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rates have remained high and only 511 participants have actively denied to continue over the 
years.  
 
Figure 4.2 Flow chart of the BAMSE cohort. The initial inclusion and the follow-ups over time are described. 
Q=Questionnaire. At the 12 and 16 year follow-ups parents and children received separate questionnaires. 
Blood=Blood sample obtained at the clinical examination.  
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4.2 EXPOSURE AND COVARIATE ASSESSMENT 
4.2.1 Questionnaire-based data 
Information on fish intake and most covariates assessed as confounders was derived from 
questionnaires. In study II we used information on current frequency of fish intake from the 
1-year questionnaire, in which the parents had five predefined response categories to choose 
from (Figure 4.3). A food frequency questionnaire (FFQ) was filled out at the 8-year clinical 
examination. The FFQ included questions on average frequency of consumption during the 
past year of 103 food and beverage items commonly consumed in Sweden. The ten 
predefined response categories ranged from never to three or more times per day. Forty 
percent of the FFQs were answered by a parent together with the child and 57% were 
answered by parent only; in total 2,614 FFQs were filled out. In one block of questions the 
frequency of consumption of fish species was asked for (Figure 4.4). We used information 
on fish consumption from the FFQ in studies II, III and IV.  
Figure 4.3 The question regarding fish consumption included in the 1-year questionnaire. 
 
How often has your child, on average, consumed the following food items at home and in school during 
the past 12 months? 
FOOD ITEMS, 
FOOD COURSES Never 
Less 
than 1 
time per 
month 
1-3 
times 
per 
month 
Times per week Times per day 
 1 2 3-4 5-6 1 2 3+ 
FISH                              
Herring, mackerel                              
                              
Salmon                              
                              
Cod, pollock, pike                              
                              
Fish fingers                              
                              
Caviar (e.g., Kalles)                              
                              
Tunafish                              
                              
Shellfish                              
 
Figure 4.4 Section on fish consumption from the food frequency questionnaire filled out at age 8 years. The 
section has been edited and translated from Swedish. 
 
47. How often does the child eat fish? 
 More than once a week 
 Once a week 
 2-3 times a month 
 Once a month or less 
 Never eats fish 
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The responses to the FFQ were calculated for individual energy and nutrient intake with the 
use of food composition values from the database at the Swedish National Food Agency.
132
 
In a first step, the intake frequency of each food item in the FFQ was multiplied with its 
nutrient content per portion. If an exact portion size was not stated in the FFQ, portion sizes 
based on the consumption in the national survey Riksmaten 2003 were used instead. 
Riksmaten 2003 is based on a representative sample of 8-9-year old children in Sweden.
133
 
Children in Riksmaten registered their food consumption in a food diary during four 
consecutive days. In a second step, nutrient values were summarized over foods and 
beverages to obtain calculated total intake of each nutrient. To remove the variation in 
nutrient intake caused by differences in total energy consumption, the calculated nutrient 
levels were energy-adjusted using the residual method suggested by Willet et al.
134
 After 
energy-adjustment with the residual method, the remaining variation was caused by 
differences in nutrient composition. Children with an implausible energy intake were 
excluded (±3 log SDs; ≤842.5 or ≥3961.1 kcal per day). In studies III and IV we used 
intakes of polyunsaturated fatty acids (PUFAs) calculated from the FFQ. In addition, in study 
III we used the calculated intake of vitamin D. 
 
The FFQ-based data on fish and PUFA intake has some limitations. FFQs are generally 
considered to give rise to some misclassification, since they often ask about consumption for 
a long time frame, for example, the preceding year. Exact portion sizes are not usually 
inquired about, but rather frequency of intake, which is then used to calculate nutrient intake 
in grams per day. FFQs are useful tools to distinguish subjects into different categories based 
on amount of intake. FFQs are often used in epidemiological studies, as they are cheap and 
easy to distribute among many participants.  
 
4.2.2 Analysis of plasma fatty acid composition 
For study IV the composition of fatty acids in plasma phospholipids was measured in blood 
samples collected at the 8-year clinical examination (Figure 4.2). For the plasma fatty acid 
analysis, 999 children were considered available. In pilot measurements, 60 of these were 
used to see if the method would work in our study population; if there were measureable 
amounts of fatty acids in the samples and if there was a range of exposure (fatty acids) for 
this group of children. In the end, 940 children had plasma composition measured, while 59 
had too small amounts of blood left in the sample (Figure 4.5). The fatty acid composition of 
plasma phospholipids was measured using gas chromatography. Fifteen different fatty acids 
were detected. Each fatty acid was then measured as the relative amount of all fatty acids in 
the sample. This method is often used instead of measuring absolute amounts, since absolute 
amounts are more complicated, more time-consuming and more expensive to measure. The 
correlation between relative and absolute amounts has been shown to be good for most fatty 
acids.
135
 One sample had an undetectable amount of α-linolenic acid (ALA, 18:3 n-3); this 
child was included in the statistical analyses of the other fatty acids.  
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The blood samples had been stored for just over ten years before the fatty acid content was 
analyzed. The samples were frozen in minus 80ºC, a temperature at which the fatty acids 
should be stable.
136
 If degradation has occurred it should affect all samples equally and 
therefore not introduce any misclassification bias.  
 
Figure 4.5 Inclusion of children to the plasma fatty acid analysis. FFQ=Food frequency questionnaire filled out 
at the 8-year clinical examination, CE=Clinical examination. 
 
4.2.3 Collection of weight and height data from school health care 
To be able to study overweight status over time in BAMSE we asked for permission in the 
12-year questionnaire to collect weight and height data from child- and school health center 
registers. We received consent to collect data for 3,151 children. Children in Sweden are 
measured and weighed regularly at child welfare centers between ages 0 and 6 years, after 
which their charts are transferred with them to school. Through the school health service they 
are measured and weighed when they start school and then in the second, fourth, sixth and 
eighth grade. The first step in the collection process was to find out about the children’s 
schools. To gain this information I turned to the municipalities where they lived. In all, 149 
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municipalities were contacted and 137 gave me the information I needed. The children 
attended 447 different schools. The second step was to contact the school nurses. For schools 
with over ten children from BAMSE in attendance, I or a colleague visited and collected the 
data. For schools with fewer children, we sent a letter with information and a data sheet to fill 
out for each child. In total, we obtained data for 2,597 children for up to ten different ages 
(Table 4.1). The amount of available data varied across the ages. 
Table 4.1 Weight and height data collected from school health centers for a sub-
population of the BAMSE cohort
1 
Source Pre-defined age (y) Time span n % of cohort 
Child health center 0.5
 
±2 w 2,317 57 
 1
 
±4 w 2,302 56 
 1.5
 
 2,259 55 
 2
 
±6 mo 1,610 39 
 3
 
 1,301 32 
 4
 
 2,271 56 
 5
 
 2,214 54 
School health center 7
 
-6 to + 11 mo 2,473 60 
 10
 
 2,252 55 
 12
 
 2,267 55 
1. Data available from a sample of those answering the 12-year questionnaire 
 
We collected weight and height data retrospectively for the subjects who gave their consent 
in the 12-year questionnaire. This method might have introduced a selection bias, if 
participants gave their consent based on their weight (see more about selection bias in section 
7.1.2.1). For children who were weighed and got their height measured at the 8-year clinical 
examination we could check if that was the case. There was no difference in the proportion of 
consent among the children who were considered overweight (isoBMI≥25 kg/m²) at age 8 
years compared with those who were considered normal weight (isoBMI<25 kg/m²) (P-value 
from chi
2
-test: 0.068). Regarding obesity status there was a significant difference, with fewer 
obese (isoBMI≥30 kg/m²) than expected among the ones who gave consent (P-value from 
chi
2
: 0.002). However, the obesity prevalence for the sub-sample of children with data from 
the collection is comparable with the prevalence for the cohort at age 8 years (3.9% [95% CI: 
3.1-4.7] vs. 4.4% [95% CI: 3.6-5.2]). Overall, we should be cautious to generalize our result 
to an obese population; there were few children classified as obese overall and I did not study 
this group separately.  
 
4.3 ALLERGIC DISEASE AND SENSITIZATION ASSESSMENT 
The information used to define allergic disease was retrieved from the questionnaires 
distributed during childhood. We relied on parental report of symptoms for children up to 12 
years of age. At 16 years of age the children themselves answered a questionnaire which we 
used to define disease. Definitions of allergic disease are described in Table 4.2.     
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Table 4.2 Definitions of allergic disease 
Variable Definition Study 
Asthma at  
ages 1 & 2y 
At least three episodes of wheeze in combination with inhaled 
steroids or signs of bronchial hyperreactivity without concurrent 
upper respiratory infection 
II 
Asthma at  
ages 4, 8, 12 & 16y 
At least four episodes of wheeze in the previous 12 months or at least 
one episode of wheeze during the same period in combination with 
occasional or regular use of prescribed inhaled steroids 
I (8y), II & IV 
(8 & 16y) 
Rhinitis at 
ages 1 & 2y 
Prolonged rhinitis symptoms, like a runny or blocked nose, for at least 
two months in the past 12 months 
II 
Rhinitis at  
ages 4, 8, 12 & 16y 
Prolonged rhinitis symptoms without a common cold in the past 12 
months 
II 
Rhinitis at ages 8 & 
16y 
Prolonged rhinitis symptoms without a common cold in the past 12 
months and/or symptoms following contact with furred pets, pollens, 
or mites 
III (16y) & IV 
(8 & 16y) 
Eczema at 
 ages 1 & 2y 
Dry skin in combination with an itchy rash at a typical location (face, 
or arm/leg extension surfaces, or arm/leg flexures, or wrist/ankle) for 
at least two weeks during the past 12 months 
OR 
A doctor’s diagnosis of eczema during the past 12 months 
II 
Eczema at 
 age 4y 
Dry skin in combination with an itchy rash at a typical location (face, 
or arm/leg extension surfaces, or arm/leg flexures, or wrist/ankle) for 
at least two weeks during the past 12 months 
OR 
Usage of cortisone ointment during the past 12 months 
II 
Eczema at 
 age 8y 
Dry skin in combination with an itchy rash at a typical location (face, 
or arm/leg flexures, or wrist/ankle, or neck) for at least two weeks 
during the past 12 months 
OR 
A doctor’s diagnosis of eczema during the past 12 months 
II 
Eczema at 
 age 12y 
Dry skin in combination with an itchy rash at a typical location (face, 
or arm/leg flexures, or wrist/ankle, or neck) for at least two weeks 
during the past 12 months 
II 
 
4.3.1 Sensitization 
Allergic sensitization was measured in blood samples provided at the three clinical 
examinations. Immunoglobulin E (IgE) antibodies in blood were analyzed with ImmunoCAP 
to common aeroallergens by using the Phadiatop
®
 mix (cat, dog and horse dander; timothy, 
birch and mugwort pollen; Cladosporium herbarum (fungi) and Dermatophagoides 
pteronyssinus (house dust mite); Thermo Fisher Specific, Uppsala, Sweden). A sample 
positive for the Phadiatop mix was analyzed further for allergen-specific IgE antibodies to the 
allergens listed above, and in addition to Dermatophagoides farinae (house dust mite) at age 
16 years. Moreover, IgE antibodies to common food allergens were also analyzed using the 
fx5
®
 mix (cow’s milk, hen’s egg, codfish, soybean, peanut, and wheat). A technical cut-off 
for a positive test was set at 0.35 kU/L, in accordance with the manufacturer’s instructions. 
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Sensitization status was used as a separate outcome and to divide the diseases into IgE-
associated and non-IgE-associated phenotypes. 
 
4.4 STUDY DESIGN & POPULATION 
All studies included in this thesis have an observational design, meaning that we as 
researchers collect data and study associations of exposure and outcome without interfering 
with the exposure. As mentioned before, the studies are based on the birth cohort BAMSE. 
 
4.4.1 Study I 
The study included 2,075 children for whom there was information available on weight and 
height at ages 1 and 7 years and on asthma at age 8 years (see Table 4.5 for more details). 
Study I was a longitudinal study, meaning that the occasions of exposure and outcome were 
separated in time, and that exposure occurred before the outcome. Longitudinal studies can be 
divided into prospective and retrospective studies. In prospective studies the exposure is 
assessed before the outcome has occurred. In contrast, in retrospective studies exposure 
information is gathered after the outcome has occurred. Although, the information on weight 
and height used in Study I was collected when the children were around 12 years of age, the 
measurements of weight and height were done when the children were 1-7 years of age. A 
potential issue regarding the weight and height data is selection bias; this is discussed further 
in the discussion section of this thesis. 
 
4.4.2 Study II     
For this study, 3,285 children were included, for whom there was information available on 
fish consumption at age 1 year and on at least one outcome at age 12 years (see Table 4.5 for 
more details). The study was longitudinal and prospective, the exposure was retrieved from 
the 1-year follow-up and information on asthma, rhinitis and eczema status was obtained 
from all follow-ups from ages 1 to 12 years (Figure 4.2). The repeated measurements of 
outcome over time in the same individual are a special case of longitudinal design which 
introduces the need for different statistical methods that can take care of the intra-correlation 
between observations. In addition, sensitization status was used from the 8-year follow-up. 
 
4.4.3 Study III 
The study included 1,970 children who had provided information on fish and nutrient intake 
at age 8 years and on outcome data at age 16 years (see Table 4.5 for more details). The 
study was longitudinal and prospective. In addition, cross-sectional association analyses 
between fish intake at age 8 years and outcome at the same age were performed, for which 
the data on exposure and outcome was collected at the same point in time. This kind of 
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analysis gives information of possible associations, but is not suitable for drawing 
conclusions about temporal relationships.  
 
4.4.4 Study IV 
The study was longitudinal and prospective and consisted of the 940 children for whom there 
was information on fatty acid proportions in plasma at age 8 years and outcome data at age 16 
years (Figure 4.5 and see Table 4.5 for more details). In addition, cross-sectional association 
analyses between fatty acid proportions at age 8 years and outcome at age 8 years were 
performed. 
 
4.5 STATISTICS  
One-sample t-test was used to compare the distribution of selected background characteristics 
in the baseline cohort with the specific study populations included in each study. 
 
4.5.1 Exposure modelling 
The exposures used in the different studies are defined in Table 4.3. The lowest category of 
exposure was always set as the reference. For test of trends in association analyses of nutrient 
variables in study III, the median intake level for each tertile was assigned to everyone in 
that tertile and used as a continuous variable. 
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Table 4.3 Modelling of exposures 
Variable Definition Study 
BMI at ages 1, 1.5, 4 & 
7y 
Body weight in kilograms divided by height in meters squared (kg/m²). 
Normal BMI vs. high BMI (≥85
th
 percentile
1
) 
I 
Change in BMI status 
between early age 
(12/18 months) & 7y, 
and between 4 & 7y 
 Persistent normal BMI (normal BMI at both early age & at 7y) 
 Early high BMI (high BMI at early age but normal BMI at age 7y) 
 Late high BMI (normal BMI at early age but high BMI at age 7y) 
 Persistent high BMI (high BMI both at early age & at age 7y) 
Classification of change between 4 & 7 years was done in the same way  
I 
At 1y, intake of:   
Fish Categorical variable (see fig 4.3) and dichotomous variable ( ≤1 
time/month (irregular) vs. ≥2-3 times/month (regular)) 
II 
At 8 y, intake of:   
Total fish Sum of herring/mackerel, salmon fishes, cod/pollock/pike, fish fingers & 
tuna fish (<2 times/week vs. ≥2 times/week) 
III 
Oily fish Sum of herring/mackerel and salmon fishes (<1 time/week vs. ≥1 
time/week) 
III 
Cod/pollock/pike <1 time/week vs. ≥1 time/week  III 
Fish fingers <1 time/week vs. ≥1 time/week  III 
Total PUFA Sum of LA, ALA, AA, EPA, DPA & DHA
2
 (Tertiles) III 
Total VLC n-3  Sum of EPA, DPA & DHA (Tertiles) III 
Total n-6 Sum of LA & AA (Tertiles) III 
n-6/n-3 The ratio of total n-6 to total n-3 (Tertiles) III 
LA, ALA, AA Used as separate exposures (Tertiles) III 
Vitamin D Tertiles III 
Plasma levels of:   
Total VLC n-3 Sum of EPA, DPA & DHA (Continuous) IV 
LA, ALA, AA Used as separate exposures. ALA was log-transformed to improve 
normality (Continuous) 
IV 
1. Based on children in the study 
2. LA=Linoleic acid (18:2 n-6); ALA=α-Linolenic acid (18:3 n-3); AA=Arachidonic acid (20:4 n-6); EPA=Eicosapentaeonic 
acid (20:5 n-3); DPA=Docosapentaeonic acid (22:5 n-3); DHA=Docosahexaeonic acid (22:6 n-3) 
 
4.5.2 Outcome modelling 
See Table 4.5 for an overview of the outcomes for the different studies. 
 
Asthma, eczema and rhinitis were dichotomized as no vs. yes based on the disease definition 
(see Table 4.2 for the definitions). For sensitization IgE≥0.35 kU/L was set as the cut-off for 
a positive test. In study I, sensitization to aeroallergens and food allergens was analyzed 
separately, while it was analyzed as total sensitization in study II. In study IV, sensitization 
to aeroallergens was defined as having a positive test to the Phadiatop
®
 mix plus at least one 
specific aeroallergen.  
 
For analyses of phenotypes of allergic disease the subjects were divided into categories; 
 No specific allergic disease and no sensitization (reference category) 
 Specific allergic disease but no sensitization (non-IgE associated phenotype) 
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 Specific allergic disease and sensitization (IgE-associated phenotype) 
For study II, total sensitization (Phadiatop
®
 and/or fx5
®
) was used, while Phadiatop
®
 was 
used to discriminate between IgE-associated and non-IgE-associated phenotypes in study III. 
In study IV, Phadiatop
®
 in addition to at least one positive test to a specific aeroallergen was 
used to discriminate between phenotypes. 
 
Incidence of disease was examined in studies II, III and IV. In study II, incidence was 
defined as fulfilling the definition of disease at the given age, but not at any previous follow-
up. In study III, children with rhinitis symptoms at 8 years of age were excluded to study 
incidence of IgE-associated (allergic) and non-IgE-associated (non-allergic) rhinitis up to age 
16 years. In study IV, incidence was defined as fulfilling the definition of disease at age 16 
years, but not at ages 4, 8 or both. 
 
4.5.3 Statistical analyses 
All statistical analyses were performed with Stata 11 software (StataCorp, College Station, 
Tx). P values below 0.05 were considered statistically significant. This is an arbitrary cut-off, 
often used in epidemiological studies. 
 
I used logistic regression to assess potential associations between exposures and dichotomous 
outcomes of allergic disease in all studies. To examine the potential associations between 
exposures and IgE-associated and non-IgE-associated phenotypes, I applied multinomial 
logistic regression in studies II, III and IV. Moreover, in study II, I used Generalized 
Estimating Equations (GEE) because of the use of repeated outcome measurements for the 
subjects. GEE takes into account within-person correlation and provides estimates when 
missing observations are unequally spaced.
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 The model incorporates an interaction between 
time and exposure to evaluate the effect of exposure over time. The results from the 
regression models and GEE are presented as odds ratios (ORs) with 95% confidence intervals 
(95% CI).  
A range of potential confounders were tested by checking each factor’s impact in the crude 
model of the exposure and the outcome in each study. The ones finally included in the 
multivariable analyses for the different studies are described in Table 4.4 and listed in Table 
4.5. Potential confounders to test for were chosen based on a priori knowledge. For a factor to 
be a confounder it needs to be associated with the exposure, have an independent effect on 
the outcome, and should not be affected by the exposure or the disease. A factor that is in the 
causal chain between exposure and outcome is a mediator and can be adjusted for only if you 
would like to study the direct effect of the exposure on the outcome, instead of the total 
effect. This was tested in study II, where I adjusted for childhood diet at age 8 years (fish, 
vitamin D, total energy and use of dietary supplements) in the analyses of infant fish 
consumption and allergic disease throughout childhood; however, additional adjustment did 
not affect the observed results. Another way to deal with confounding is to stratify the 
 28 
analyses by the potential confounding factor. In studies I and II, I stratified by parental 
allergic disease.   
 
Table 4.4 Definition and modelling of confounders 
Variable Definition Study 
Sex Female vs. male I, II & IV 
Parental allergic 
disease 
Mother and/or father with a doctor’s diagnosis of asthma & asthma 
medication and/or a doctor’s diagnosis of hay fever in combination with 
furred pet and/or pollen allergy (no vs. yes) 
I, II & IV 
Maternal smoking  Mother smoked at least one cigarette per day at any time point during 
pregnancy or when the child was an infant (no vs. yes) 
I, II 
Maternal age Maternal age at birth of the child (>25y vs. ≤25y) I 
Birth weight In grams (tertiles) I 
Breastfeeding 
duration 
Exclusive breastfeeding without exposure to formula (cow’s milk or 
hydrolysate) or solid foods (>4 month vs. ≤4 month)  
I 
Total intake of 
carbohydrates 
g/day (continuous) III 
Total intake of 
monounsaturated 
fat 
g/day (continuous) III 
 
A potential problem that can affect observed ORs is disease-related modification of exposure. 
This is typically not a problem in longitudinal studies because the exposure is measured 
before the disease of interest. However, disease-related modification of exposure can be 
problematic in the case of allergic disease, because many children have transient asthma-like 
symptoms and dry skin during the first years of life or might have allergic parents, 
characteristics which might lead to changes of their dietary habits, for example their fish 
consumption. This particular problem was addressed through different sensitivity analyses in 
the different studies. In studies I, III and IV additional adjustment for early symptoms of 
allergic disease, defined as reported symptoms of wheeze, eczema or both during the first 2 
years of life, was performed. In addition, in study I, children with reported wheeze between 
the ages 3 months and 1 year and with reported doctor’s diagnosis of asthma during the first 2 
years of life were excluded from secondary analyses. Children with symptoms of wheeze, 
eczema or both during the first year of life were excluded in study II. Finally, interactions 
between exposures and parental allergic disease were tested with Wald test or Likelihood 
ratio test in studies II, III and IV.     
  
 29 
 
Table 4.5 Overview of the studies 
 Study I Study II Study III Study IV 
Follow-ups 
used 
Weight & height 
from SHC
1
 
(permission in Q
2
12), 
Q0-8, CE
3
8 
Q0-12, CE8, FFQ8
4
 Q0, Q1, Q2, Q8, 
Q16, Qc16
5
, FFQ8, 
CE16 
Q0, Q1, Q2, Q8, 
Qc16, FFQ8, CE4-
CE16, plasma FA 
data
6
 
N, % of the 
cohort 
2,075, 51% 3,285, 80% 1,970, 48% 940, 23% 
Inclusion 
criteria 
Q0-8, weight & 
height at 1 & 7y, 
asthma at 8y 
Q0, fish intake at 1y, 
≥1 outcome at 12y 
Q0, nutrient & total 
fish intake at 8y, 
outcome data at 
16y 
Q0, plasma FA, 
outcome data at 
16y 
Exposures BMI
7 
at age 1, 1.5, 4 
& 7y 
Infant fish intake Fish & PUFAs intake 
at school age 
Plasma PUFAs at 
age 8y 
Outcomes Prevalent asthma & 
sensitization 
 8y 
Prevalent & incident 
asthma, rhinitis & 
eczema 1-12y 
Incident rhinitis 
between 8 & 16 y 
Prevalent & incident 
asthma, rhinitis & 
aeroallergen 
sensitization 
8 & 16y 
Allergic and 
non-allergic 
phenotypes
 
 8y 16y 16y 
Confounders 
adjusted for 
Sex, parental allergic 
disease, maternal 
smoking, maternal 
age, birth weight, 
breastfeeding 
duration  
Sex, parental 
allergic disease, 
maternal smoking 
Fish analyses adj for 
the other types of 
fish. PUFA & vit D 
analyses adj for 
total intake of 
carbohydrates, 
monounsaturated 
fat & the other 
exposures 
Sex, parental 
allergic disease 
Statistical 
methods for 
association 
analyses 
Multivariable log 
reg. 
GEE. Multivariable 
log reg. Multinomial 
log reg. 
Multinomial log reg. Multivariable log 
reg. Multinomial log 
reg. Spearman rank 
correlation test 
1. SHC=School health center 
2. Q=Questionnaire at age 1 to 16 years 
3. CE=Clinical examination at age 4, 8 & 16 years 
4. FFQ=Food frequency questionnaire at age 8 years 
5. Qc=Questionnaire answered by the children themselves 
6. Plasma FA data=FA proportions measured in plasma phospholipids 
7. BMI=Body mass index (kg/m
2
) 
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5 ETHICAL APPROVALS 
All participants in BAMSE have given their informed consent. All have been informed that 
they have the right to withdraw their participation in each follow-up. All follow-ups of the 
BAMSE study were approved by the ethical review board at Karolinska Institutet, 
Stockholm, Swede
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6 RESULTS  
6.1 BODY MASS INDEX IN RELATION TO ASTHMA AND ALLERGIC 
SENSITIZATION AT AGE 8 YEARS 
The distribution of background characteristics for the 2,075 children included in study I (the 
inclusion criteria are found in Table 4.5) was comparable to the baseline cohort. The 
prevalence of high body mass index (BMI) ranged between 14 and 15% at ages 1 year, 1.5 
years, 4 years and 7 years. Children with a high BMI at an early age (1 year and/or 1.5 years) 
were more likely to have been exposed to maternal smoking during pregnancy and/or infancy 
and were in general heavier at birth (see Table 1 in study I). At age 8 years, a total of 124 
children fulfilled the definition of asthma, 402 children were sensitized to aeroallergens and 
310 children to food allergens.  
 
A high BMI at ages 1, 4 and 7 years was associated with an increased risk of asthma at age 8 
years (ORadj: 1.62 [95% CI: 1.01-2.60] for high BMI at age 1 year, ORadj: 1.72 [95% CI: 
1.06-2.80] for high BMI at age 4 years, and ORadj: 2.13 [95% CI: 1.36-3.35] for high BMI at 
age 7 years). When we tried to disentangle the timing of high BMI, by dividing the children 
into different categories based on their BMI status at each age, we observed that children who 
had a high BMI at early age or 4 years but a normalized BMI at age 7 years had no increased 
risk of asthma at age 8 years (Figure 6.1). In contrast, there was a significant association 
between late high BMI and an increased risk of asthma at age 8 years. In addition, a persistent 
high BMI between ages 4 and 7 years was associated with an increased risk of asthma at age 
8 years.  
 
 
Figure 6.1 Association between change in BMI status and asthma at age 8 years in multivariable analyses 
adjusted for sex, parental allergic disease, maternal smoking, maternal age, birth weight, and breastfeeding 
duration. 
 Persistent high 
 Late high 
 Early high 
 Persistent normal 
 Btw 4 and 7y 
 Persistent high 
 Late high 
 Early high 
 Persistent normal 
 Btw 1-1.5 and 7y 
.5 1 2 3 4 5 
Odds ratio (95% CI) 
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To address the issue of a possible effect of early symptoms of allergic disease on BMI, the 
analyses were additionally adjusted for early symptoms of allergic disease (wheeze and/or 
eczema during the first 2 years of life). The additional adjustment did not affect the observed 
associations. We also excluded children with reported wheeze during the first year of life and 
a reported doctor’s diagnosis of asthma during the first 2 years of life. Among the 1,698 
children in the analyses after exclusion, a high BMI at age 7 years was still associated with 
asthma at age 8 years (ORadj: 2.48 [95% CI: 1.40-4.38]), whereas a high BMI at earlier ages 
was not. 
 
High BMI at age 1 and 7 years, respectively, was associated with an increased risk of 
sensitization to aeroallergens at age 8 years (ORadj: 1.43 [95% CI: 1.04-1.96] for high BMI at 
age 1 year, and ORadj: 1.42 [95% CI: 1.02-1.97] for high BMI at age 7 years). In analyses of 
change in BMI status, early high BMI was not associated with aeroallergen sensitization at 
age 8 years, while children who had developed a high BMI between early age and 7 years had 
an increased risk of being sensitized to aeroallergens (ORadj: 1.59 [95% CI:1.06-2.39]).  We 
did not observe any significant associations between high BMI and food sensitization (data 
not shown).  
 
6.2 FISH CONSUMPTION IN RELATION TO ALLERGIC DISEASE 
6.2.1 Infant fish consumption and allergic disease up to age 12 years 
The 3,285 children included in study II (inclusion criteria are found in Table 4.5) were 
comparable to the children in the baseline cohort, except that they had a somewhat higher 
prevalence of white collar workers among their parents (83.2% vs. 81.6%) (see Table 1 in 
study II). Eighty percent of the children had a regular consumption of fish (2 times/month or 
more) at age 1 year. Parental allergic disease and early symptoms of allergic disease (wheeze 
and/or eczema during the first year of life) delayed the introduction of fish and led to lower 
intake at age 1 year (P<0.001). The prevalence of asthma was stable from age 1 to 12 years 
(see Table 2 in study II). Rhinitis prevalence increased during school ages, while the 
prevalence of eczema decreased during the same time period. The incidence of the different 
diseases followed the same patterns. At age 12 years, 218 children fulfilled the definition of 
asthma, 681 fulfilled the definition of rhinitis and 392 fulfilled the definition of eczema.     
 
The associations between fish intake (per category) at age 1 year and overall risk of asthma, 
rhinitis and eczema (1-12 years) are displayed in Figure 6.2. Increased fish intake at age 1 
year was inversely associated with overall reduced risk of asthma (P trend<0.001), rhinitis (P 
trend<0.001) and eczema (P trend<0.001). Restriction to children without early symptoms of 
allergic disease attenuated the observed associations; the inverse association with rhinitis was 
the only one still significant (ORadj: 0.63 [95% CI: 0.46-0.87] comparing the highest with the 
lowest intake, P trend<0.001).  
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Figure 6.2 Associations between categorical fish intake at age 1 year and overall risk of asthma, rhinitis and 
eczema (1-12 years) in multivariable GEE analyses adjusted for sex, parental allergic disease, and maternal 
smoking. The associations are displayed for all children (circles) and after restriction to children without 
symptoms of allergic disease during the first year of life (triangles).  
 
Analyses of dichotomized fish consumption revealed reduced risks of asthma, rhinitis and 
eczema over all time points (1-12 years) for children with regular intake (≥2-3 times/month) 
compared with children with irregular intake (≤1 time/month) (see Figures 1, 2 and 3 in 
study II). The estimates for eczema became gradually closer to one and were non-significant 
at age 12 years in contrast to the estimates for asthma and rhinitis, which were more stable 
over time. After restricting the analyses to children without early symptoms of allergic 
disease, regular fish intake at age 1 year was associated with a reduced risk of overall rhinitis 
(ORadj: 0.74 [95% CI: 0.60-0.90]) and eczema (ORadj: 0.78 [95% CI: 0.63-0.97]).  
 
The estimates for incidence of asthma, rhinitis and eczema were similar overall to the 
estimates for prevalent asthma, rhinitis and eczema (see Figures 1, 2 and 3 in study II). After 
restriction of the analyses to children without early symptoms of allergic disease regular fish 
intake at age 1 year was still associated with a reduced risk of incident rhinitis (ORadj: 0.78 
[95% CI: 0.63-0.95]).    
 
Regular fish intake at age 1 year was associated with a reduced risk of aeroallergen and/or 
food sensitization at age 8 years (ORadj: 0.78 [95% CI: 0.63-0.96]). After restriction to 
children without early symptoms of allergic disease the association vanished (ORadj: 0.98 
[95% CI: 0.73-1.30]).  
 
In analyses of IgE-associated and non-IgE-associated disease at age 8 years, the only 
significant association, after restriction to children without early symptoms of allergic 
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disease, was observed for non-IgE-associated rhinitis (ORadj: 0.36 [95% CI: 0.21-0.63]) 
(Figure 6.3). 
   
Figure 6.3 Associations between a regular fish intake at age 1 year (≥2-3 times/month) and non-IgE-associated 
and IgE-associated phenotypes of asthma, rhinitis and eczema at age 8 years, in multivariable analyses adjusted 
for sex, parental allergic disease, and maternal smoking. The associations are displayed for all children (circles) 
and after restriction to children without symptoms of allergic disease during the first year of life (triangles). 
 
6.2.2 Childhood fish consumption and development of rhinitis 
The distribution of characteristics for the 1,970 children included in study III (inclusion 
criteria are found in Table 4.5) was comparable to the children in the baseline cohort; only 
minor differences were observed (see Table EI in the online repository of study III). The 
median intake of fish at age 8 years was 1.7 times/week and 38% consumed fish two times 
per week or more. Fourteen percent consumed oily fish once per week or more, while 
cod/pollock/pike and fish fingers were consumed regularly by 32% and 38%, respectively. 
The cumulative incidence of IgE-associated rhinitis (AR) and non-IgE-associated rhinitis 
(NAR) between ages 8 and 16 years was 21% (n=337) and 15% (n=236), respectively. Other 
characteristics of the study population are found in Table I in study III.  
 
Total fish intake at age 8 years was not associated with incidence of AR or NAR between 
ages 8 and 16 years. In analyses of types of fish we observed that regular intake of oily fish 
was associated with a reduced risk of incident NAR (ORadj: 0.52 [95% CI: 0.32-0.87]). The 
association with AR was in the same direction but did not reach statistical significance 
(ORadj: 0.78 [95% CI: 0.53-1.15]). No clear associations were observed between 
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 Non-IgE-ass. eczema 
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 IgE-ass. asthma 
 Non-IgE-ass. asthma 
No asthma and no sens 
.5 1 2 3 
Odds ratio (95% CI) 
All Restricted 
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cod/pollock/pike or fish fingers and AR or NAR (Figure 6.4). Fish intake at age 8 years was 
not associated with AR or NAR at age 8 years. 
 
Additional adjustment for early symptoms of allergic disease (wheeze and/or eczema during 
the first 2 years of life) did not affect the observed associations between oily fish and incident 
NAR (ORadj: 0.48 [95% CI: 0.28-0.82]). 
 
Figure 6.4 Association between intake of different types of fish at age 8 years and incidence of AR and NAR 
between ages 8 and 16 years. The association for each type of fish was adjusted for the other types of fish.  
 
Since the results for AR and NAR went in the same direction, cases of AR and NAR were 
combined in post hoc analyses to raise the comparability with previously published results. 
Oily fish was associated with a reduced risk of incident rhinitis between ages 8 and 16 years 
(ORadj: 0.67 [95% CI: 0.48-0.97]). 
 
6.3 POLYUNSATURATED FATTY ACIDS IN RELATION TO ALLERGIC 
DISEASE 
6.3.1 Polyunsaturated fatty acid intake and development of rhinitis 
The median intake of total polyunsaturated fatty acids (PUFAs), total n-6 fatty acids (the sum 
of linoleic acid [LA, 18:2] and arachidonic acid [AA, 20:4]) and total VLC n-3  fatty acids 
(the sum of eicosapentaeonic acid [EPA, 20:5], docosapentaeonic acid [DPA, 22:5], and 
docosahexaeonic acid [DHA, 22:6]) for the 1,970 children in study III were 7.9 g/day, 6.2 
g/day and 0.2 g/day, respectively (Table 6.1). Salmon was the major source for intake of total 
VLC n-3 fatty acids, while the dietary sources for total n-6 fatty acids were more diverse 
(Figure 6.5). The cumulative incidence of AR and NAR between ages 8 and 16 years were 
21% (n=337) and 15% (n=236), respectively. 
AR NAR 
0.5 
0.8 
1.0 
2.0 
O
d
d
s
 r
a
ti
o
 (
9
5
%
 C
I)
 
 O
ily
 f
is
h
  
 C
o
d
/p
o
llo
c
k
/p
ik
e
  
 F
is
h
 f
in
g
e
rs
    
 O
ily
 f
is
h
  
 C
o
d
/p
o
llo
c
k
/p
ik
e
  
 F
is
h
 f
in
g
e
rs
  
 38 
Table 6.1 Consumption of PUFAs
1
 and vitamin D at age 8 years, for the study 
population (N=1,970), and for adolescents with incidence of IgE-associated rhinitis 
(AR, n=337) or non-IgE-associated rhinitis (NAR, n=236) between ages 8 and 16 years 
 Study population Incident AR Incident NAR 
PUFA (g/day) Median IQR
2 
Median IQR
2 
Median IQR
2 
Total PUFA 7.9 9.6-6.5 7.9 9.6-6.6 8.0 9.7-6.4 
ALA
3 
1.1 1.4-0.9 1.1 1.4-0.9 1.2 1.5-0.9 
VLC n-3
4 
0.2 0.3-0.1 0.2 0.3-0.2 0.2 0.3-0.1 
n-6
5 
6.2 7.6-5.2 6.3 7.6-5.2 6.2 7.9-5.2 
LA 6.2 7.5-5.1 6.2 7.5-5.2 6.2 7.7-5.1 
AA 0.1 0.09-0.06 0.1 0.09-0.06 0.1 0.09-0.05 
n-6/n-3 ratio 4.6 4.9-4.2 4.6 4.9-4.2 4.7 5.0-4.3 
Vitamin D 
(µg/day) 
5.1 6.5-3.9 5.1 6.4-3.9 5.3 6.4-3.9 
1. PUFAs=Polyunsaturated fatty acids 
2. IQR=Interquartile range 
3. ALA=α-linolenic acid (18:3 n-3) 
4. Sum of eicosapentaeonic acid (EPA, 20:5 n-3), docosapentaeonic acid (DPA, 22:5 n-3) and 
docosahexaeonic acid (EPA, 22:6 n-3) 
5. Sum of  linoleic acid (LA, 18:2 n-6) and arachidonic acid (AA, 20:4 n-6)  
 
 Figure 6.5 Sources for dietary consumption of total VLC n-3 fatty acids (A, sum of EPA, DPA and DHA) and n-6 
fatty acids (B, sum of LA and AA) for the 1,970 children in the study population.  
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A higher intake of total VLC n-3 fatty acids was associated with a reduced risk of incident 
NAR between ages 8 and 16 years (ORadj: 0.45 [95% CI: 0.30-0.67] for highest vs. lowest 
tertile, P trend<0.001). In addition, a higher ratio of n-6/n-3 fatty acids was associated with an 
increased risk of incident NAR (ORadj: 1.56 [95% CI: 1.03-2.33] for highest vs. lowest tertile, 
P trend<0.032). No apparent associations were observed for total PUFA, total n-6 fatty acids 
and the single fatty acids ALA, LA and AA (see Table IV in study III). No evident 
associations were observed between vitamin D and incident AR or NAR. 
 
Additional adjustment for early symptoms of allergic disease (wheeze and/or eczema during 
the first 2 years of life) did not affect the observed associations between total VLC n-3 fatty 
acids (ORadj: 0.43 [95% CI: 0.28-0.65] for highest vs. lowest tertile), or the ratio of n-6/n-3 
fatty acids (ORadj: 1.56 [95% CI: 1.04-2.33] for highest vs. lowest tertile) and incident NAR.  
 
In the same manner as for the analyses of fish, cases of AR and NAR were combined in post 
hoc analyses to raise the comparability with previously published results. A higher intake of 
total VLC n-3 fatty acids was associated with a reduced risk of incident rhinitis between ages 
8 and 16 years (ORadj: 0.73 [95% CI: 0.55-0.98] for highest vs. lowest tertile, P trend=0.034). 
In contrast, the association between the ratio of n-6/n-3 fatty acids and incident rhinitis was 
non-significant (ORadj: 1.28 [95% CI: 0.96-1.74] for highest vs. lowest tertile, P 
trend<0.100).     
Additional results not published in study III 
Supplementation with VLC n-3 fatty acids was reported for 13 children at age 8 years and for 
237 children at age 16 years. Additional adjustment for VLC n-3 fatty acid supplementation 
did not affect the association between intake of total VLC n-3 fatty acids at age 8 years and 
incident NAR between ages 8 and 16 years (data not shown). 
 
In analyses of PUFA and vitamin D intake at age 8 years and AR and NAR at the same age, 
we observed that vitamin D intake was significantly associated with an increased risk of AR 
(Table 6.2). In addition, total PUFA and ALA were significantly associated with an increased 
risk of NAR.  
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Table 6.2 Odds ratios (ORs) of IgE-associated (AR) or 
non-IgE-associated (NAR) rhinitis at age 8 years
1
 in 
relation to dietary PUFA (g/day) and vitamin D 
(µg/day) in tertiles at age 8 years (N=1,970) 
 
AR (n=263) NAR (n=108) 
Adjusted OR
2  
(95% CI)
 
Adjusted OR
2  
(95% CI)
 
Total PUFA   
Q2  1.38 (0.96-1.98) 1.35 (0.78-2.34) 
Q3 1.29 (0.83-1.98) 2.16 (1.17-3.99) 
P for trend
3
 0.344 0.012 
ALA   
Q2 1.10 (0.75-1.61) 1.69 (0.92-3.08) 
Q3 1.29 (0.79-2.09) 2.27 (1.07-4.83) 
P for trend
3 
0.301 0.039 
VLC n-3    
Q2  1.01 (0.72-1.41) 1.09 (0.68-1.74) 
Q3 1.20 (0.85-1.71) 0.70 (0.40-1.20) 
P for trend
3
 0.300 0.203 
n-6   
Q2 1.23 (0.83-1.82) 1.17 (0.64-2.14) 
Q3 1.04 (0.63-1.71) 1.71 (0.84-3.47) 
P for trend
3 
0.961 0.106 
LA   
Q2 1.19 (0.80-1.77) 1.20 (0.65-2.20) 
Q3  1.01 (0.61-1.68) 1.58 (0.77-3.26) 
P for trend
3
 0.897 0.188 
AA   
Q2 1.35 (0.95-1.92) 1.71 (1.03-2.85) 
Q3 1.21 (0.81-1.81) 1.64 (0.90-2.99) 
P for trend
3
 0.439 0.123 
n-6/n-3 ratio   
Q2 0.89 (0.64-1.24) 0.94 (0.57-1.57) 
Q3 0.90 (0.63-1.29) 1.34 (0.80-2.25) 
P for trend
3 
0.565 0.252 
Vitamin D   
Q2 1.79 (1.11-2.89) 1.92 (0.96-3.86) 
Q3 2.28 (1.03-5.01) 1.94 (0.64-5.82) 
P for trend
3
 0.041 0.257 
P values of 0.05 or smaller are considered significant and 
shown in boldface 
1.
 
The reference group in analyses is children without 
sensitization and rhinitis symptoms at age 8 years 
2. Model adjusted for intakes of carbohydrates, 
monounsaturated fatty acids, vitamin D, and the fatty acids 
used as exposures 
3. Test for trend with median value of each exposure 
category 
 
6.3.2 Plasma composition of polyunsaturated fatty acids and allergic 
disease at ages 8 and 16 years 
The 940 children, included in study IV, were comparable with the children in the cohort, 
except that they had a somewhat higher prevalence of parental allergic disease (33.7% vs. 
29.7%), and white collar workers among their parents (86.8% vs. 81.6%), and were fewer 
boys (45.7% vs. 50.5%) (see Table E2 in the online repository of study IV). The inclusion 
criteria can be found in Table 4.5. The median proportion of total VLC n-3 fatty acids, ALA, 
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LA and AA, as percentage of total fat were 3.3 (IQR: 4.1-2.6), 0.2 (IQR: 0.28-0.19), 21.2 
(IQR: 22.5-19.9) and 5.6 (IQR: 6.6-4.7), respectively, in plasma phospholipids at age 8 years. 
At age 16 years, 86, 413, and 419 children fulfilled the definition of asthma, rhinitis, and 
aeroallergen sensitization, respectively. The number of incident cases between ages 8 and 16 
years of asthma, rhinitis, and aeroallergen sensitization were 43, 242, and 158, respectively.   
 
In the analyses of plasma proportions of different PUFAs at age 8 years and allergic disease 
we used exposures as continuous variables. An increased proportion of total VLC n-3 fatty 
acids was inversely associated with asthma (ORadj: 0.64 [95% CI: 0.50-0.82] per 1% 
increase), rhinitis (ORadj: 0.73 [95% CI: 0.61-0.87] per 1% increase) and aeroallergen 
sensitization (ORadj: 0.77 [95% CI: 0.66-0.90] per 1% increase) at the same age. Similar 
associations were observed for AA (ORadj: 0.80 [95% CI: 0.67-0.96] per 1% increase, for 
asthma, ORadj: 0.78 [95% CI: 0.68-0.88] per 1% increase, for rhinitis, and ORadj: 0.76 [95% 
CI: 0.68-0.86] per 1% increase, for aeroallergen sensitization). No evident associations were 
observed for ALA and LA. 
 
The associations between continuous plasma proportions of PUFAs at age 8 years and 
prevalent and incident allergic disease between ages 8 and 16 years can be seen in Figure 
6.6. Increasing plasma proportion of total VLC n-3 fatty acids was inversely associated with 
asthma, rhinitis and aeroallergen sensitization at age 16 years, as well as with incident asthma 
between ages 8 and 16 years (ORadj: 0.67 [95% CI: 0.47-0.94] per 1% increase).  
 
Figure 6.6 The associations between continuous plasma proportions of total VLC n-3 fatty acids, ALA, LA and AA 
and prevalent (circles) and incident (triangles) asthma, rhinitis, and aeroallergen sensitization between ages 8 
and 16 years, in multivariable analyses adjusted for sex and parental allergic disease. 
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For ALA, we observed an inverse association with aeroallergen sensitization; the OR for 
incidence was 0.41 for an increase of 1% (95% CI: 0.22-0.79) (Figure 6.6). In contrast, LA 
was not associated with any of the outcomes. AA was inversely associated with asthma and 
aeroallergen sensitization, moreover, a borderline significant association with rhinitis was 
observed (ORadj: 0.93 [95% CI: 0.84-1.02] per 1% increase). In addition, there was a 
borderline significant association between AA and a reduced risk of incident asthma (ORadj: 
0.79 [95% CI: 0.62-1.01] per 1% increase). 
 
To investigate the possible impact of disease-related modification of exposure on the 
observed associations between plasma proportions of VLC n-3 fatty acids, ALA and AA and 
allergic disease at age 16 years, we additionally adjusted the analyses for early symptoms of 
allergic disease (wheeze and/or eczema during the first 2 years of life) and for symptoms of 
cow’s milk allergy up to age 8 years. The adjustments had limited impact on the observed 
ORs (Figure 6.7).  
 
Figure 6.7 The associations between continuous plasma proportions of total VLC n-3 fatty acids, ALA, and AA 
and asthma, rhinitis and aeroallergen sensitization at age 16 years, in multivariable analyses adjusted for sex 
and parental allergic disease (circles). Additional adjustments were made for symptoms of allergic disease up to 
age 2 years (triangles) and for cow’s milk allergy up to age 8 years (squares). 
 
In analyses of phenotypes of allergic disease at age 16 years we observed an inverse 
association of total VLC n-3 fatty acids with IgE-associated asthma (ORadj: 0.52 [95% CI: 
0.38-0.71] per 1% increase), but not with non-IgE-associated asthma (ORadj: 1.19 [95% CI: 
0.75-1.88] per 1% increase) (Figure 6.8). Total VLC n-3 fatty acids was also significantly 
associated with IgE-associated rhinitis (ORadj: 0.81 [95% CI: 0.69-0.94] per 1% increase), 
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while the association with non-IgE-associated rhinitis was non-significant (ORadj: 0.92 [95% 
CI: 0.75-1.14] per 1% increase). For AA, we observed an inverse association with IgE-
associated asthma (ORadj: 0.61 [95% CI: 0.49-0.76] per 1% increase) and rhinitis (ORadj: 0.85 
[95% CI: 0.75-0.96] per 1% increase), but not with the non-IgE-associated phenotypes. 
 
Figure 6.8 The associations between continuous plasma proportions of total VLC n-3 fatty acids (A), and AA (B) 
and non-IgE-associated, and IgE-associated phenotypes of asthma and rhinitis at age 16 years, in multivariable 
analyses adjusted for sex and parental allergic disease.  
Additional results not published in study IV 
Supplementation with VLC n-3 fatty acids was reported for 8 children at age 8 years and for 
142 children at age 16 years. Additional adjustment for VLC n-3 fatty acid supplementation 
did not affect the observed associations between proportions of VLC n-3 fatty acids at age 8 
years and asthma, rhinitis, and aeroallergen sensitization at age 16 years (data not shown).  
 
6.4 THE RELATION BETWEEN CALCULATED INTAKE AND PLASMA 
PROPORTIONS OF POLYUNSATURATED FATTY ACIDS 
The association between the calculated intake of the different PUFAs and the proportions 
measured in plasma phospholipids of the same PUFAs at the same age were estimated with 
the Spearman rank correlation test and the results are presented in Table 6.3. The correlations 
did not differ between children with or without allergic disease or aeroallergen sensitization 
at age 8 years. 
  
 
 
 
 
  
  
  
  
  
  
.5 1 1.5 2 
OR (95% CI) 
per 1% increase in total VLC n-3 
A. 
  
  
  
  
  
  
.5 1 1.5 2 
OR (95% CI) 
per 1% increase in AA 
B. 
No asthma and no 
sensitization (n=484) 
Non-IgE-ass. asthma 
(n=17) 
IgE-ass. asthma (n=69) 
No rhinitis and no 
sensitization (n=383) 
Non-IgE ass. rhinitis 
(n=113) 
IgE-ass. rhinitis (n=292) 
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Table 6.3 Spearman rank correlations between fatty acid intake (as percentage of 
total fat intake) calculated from a food frequency questionnaire and plasma 
proportions of fatty acids (as percentage of total amount fatty acids analyzed), 
stratified by allergic disease status at age 8 years
1 
 Study population 
(N=940) 
Current allergic 
disease (n=343) 
No current allergic 
disease (n=596) 
Fatty acid
2 
r
3 
P
4 
r
3 
95% CI r
3 
95% CI 
ΣVLC n-3  0.23 <0.001 0.26 0.16-0.36 0.21 0.14-0.29 
EPA 0.19 <0.001 0.23 0.13-0.33 0.17 0.09-0.24 
DPA 0.04 0.28 0.06 -0.04-0.17 0.01 -0.07-0.09 
DHA 0.29 <0.001 0.32 0.23-0.42 0.27 0.20-0.34 
ALA 0.06 0.08 0.06 -0.05-0.16 0.06 -0.02-0.14 
LA 0.02 0.46 -0.02 -0.12-0.09 0.05 -0.03-0.13 
AA 0.08 0.01 0.10 -0.001-0.21 0.08 0.004-0.16 
1. Asthma, rhinitis or aeroallergen sensitization 
2. ΣVLC n-3: the sum of very long chain omega 3 fatty acids (Eicosapentaeonic acid [EPA, 
20:5], Docosapentaeonic acid [DPA, 22:5] and Docosahexaeonic acid [DHA, 22:6]); ALA: α-
linolenic acid, 18:3 n-3; LA: Linoleic acid, 18:2 n-6; AA: Arachidonic acid, 20:4 n-6 
3. Spearman rank correlation 
4. P value for the correlation  
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7 DISCUSSION 
7.1 METHODOLOGICAL CONSIDERATIONS  
7.1.1 Precision 
The precision of a study can be explained as the degree to which the observed results are not 
due to chance. High precision means that repetition of the study would give the same results. 
The precision can be affected by random errors. Random errors originate from sampling 
variability and can be reduced by increasing the study size. The amount is reflected by the 
confidence intervals; wider confidence intervals imply more random error. The confidence 
intervals in studies I-IV are overall quite narrow. However, in some of the sub-analyses we 
observed very wide confidence intervals, which imply that we should be cautious in our 
interpretation of the results. This is the case for example in the stratification by parental 
allergic disease in study I.   
 
7.1.2 Validity  
A study with high validity measures what it is supposed to measure, the effect of systematic 
errors is small and the observed risk estimates are close to the true ones. Unfortunately, we 
will never know the true values; instead, we must try to reduce the systematic errors. 
Systematic errors that can be problematic in epidemiological studies are divided into three 
different categories: selection bias, information bias and confounding.  
7.1.2.1 Selection 
If the persons who choose not to participate in a prospective cohort have another frequency of 
exposure or outcome than the ones who choose to participate, their non-participation would 
result in a cohort not representative of the target population. Non-participation in cohort 
studies is unlikely to bias the associations between exposure and outcome since the outcome 
has not occurred at the time of inclusion and the associations are explored within the cohort. 
In any case, non-participation can affect generalizability and create a need to be careful about 
reporting prevalence rates, since they will not reflect the true prevalence rates in the general 
population.   
 
The BAMSE birth cohort included 4,089 children out of 7,221 born in the catchment area 
during the recruitment period. A short questionnaire was sent out to 1,418 non-responders 
and excluded families to check possible selection bias, the response rate was 67%.
138
 Parental 
smoking was more common among non-participants compared with participants, but no other 
characteristics differed, including parental allergic disease. Thus, the cohort is reasonably 
representative of the target population and the selection should not have led to bias in the 
associations under study.  
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Selection bias can, in longitudinal studies, be introduced at each follow-up. It is important to 
consider who has continued their participation, and who thereby has been eligible for the 
different studies. All longitudinal studies suffer from drop-out. Drop-out means that 
participants in the cohort decline to continue their participation and selection bias can be 
introduced if this depends on a specific factor. As seen in Table 7.1 there were no major 
differences in the distribution of baseline characteristics between the original cohort and 
children followed up to ages 8 and 16 years, respectively. The participation rate has 
continued to be high in BAMSE all the way up to age 16 years, when 76% of the adolescents 
answered the questionnaire and 63% attended the clinical examination.  
 
Table 7.1 Distribution of baseline characteristics among the children in the cohort, and the children 
followed up to ages 8 and 16 years
1
  
 Cohort
2
 
(N=4,089)
 
Q8
3 
(n=3,417) 
CE8
4 
(n=2,614) 
Q16
5 
 (n=3,181) 
CE16
6 
(n=2,547) 
 n % n % n % n % n % 
Sex 
Boy 
 
2,065 
 
50.5 1,726 50.5 1,333 51.0 1,579 49.6 1,236 48.5 
Maternal smoking
 
Yes 
 
563 
 
13.8 440 12.9 334 12.8 415 13.1 310 12.2 
Breastfeeding 
≥4 months 
 
3,116 
 
79.5 2,703 80.8 2,079 81.2 2,498 80.3 2,014 80.7 
Socioeconomic 
status 
White collar 
worker 
 
3,323 
 
81.6 2,836 83.2 2,185 83.8 2,641 83.3 2,128 83.9 
Parental allergic 
disease
 
Yes 
 
1,200 
 
29.7 1,027 30.3 817 31.5 969 30.8 793 31.4 
Eczema up to age 
2y 
Yes 
 
987 
 
25.8 849 25.7 697 27.5 791 25.8 645 26.1 
Any wheeze up to 
age 2y 
Yes 
 
997 
 
26.1 851 25.8 675 26.6 795 25.9 646 26.2 
1. Some of the variables contain missing  
2. Cohort refers to the original cohort of 4,089 children 
3. Q8 refers to the group of children who responded to the 8-year questionnaire 
4. CE8 refers to the group of children who attended the clinical examination at age 8 years and responded to the food 
frequency questionnaire  
5. Q16 refers to the group of children who responded to the 16-year questionnaire 
6. CE16 refers to the group of children who attended the clinical examination at age 16 years and left a blood sample 
 
Selection bias can also be introduced by the inclusion criteria for the different studies 
included in this thesis. In comparisons of the prevalence of the different allergic diseases 
included in each study with the prevalence of that allergic disease in the cohort, I found them 
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to be similar overall (Table 7.2). However, the study population for study IV had slightly 
higher prevalence of all outcomes under study compared with the cohort, with the largest 
difference for specific aeroallergen sensitization at age 16 years (44.6% vs. 40.8%). On the 
other hand, only minor differences in the distribution of background characteristics have been 
observed between the specific study population and the cohort in both study IV and the other 
studies (see more details in the different studies, reproduced at the end of this thesis). The 
small differences are not likely to affect the association between exposure and outcome.  
 
Table 7.2 Prevalence of allergic disease as defined in each study for the cohort and 
the different study populations (%) 
Outcome Cohort Study I Study II Study III Study IV 
At age 8 years      
Asthma 6.3 6.0 6.4  9.4 
Rhinitis
1 
13.6  13.7   
Rhinitis
2 
18.2    20.5 
Eczema 12.9  12.9   
Any aeroallergen 
sensitization
3 
26.0 24.9 26.1   
Specific aeroallergen 
sensitization
4 
25.2    27.5 
At age 12 years      
Asthma 6.6  6.8   
Rhinitis
1 
20.8  20.9   
Eczema 11.9  11.9   
At age 16 years      
Asthma 7.6    9.2 
Rhinitis
2 
43.9    44.3 
Specific aeroallergen 
sensitization
4 
40.8    44.6 
Non-IgE-associated 
rhinitis 
16.0   14.8  
IgE-associated 
rhinitis 
21.2   21.2  
1. Prolonged rhinitis symptoms without a common cold in the past 12 months 
2.In addition to 1: symptoms following contact with furred pets, pollens or mites 
3. A positive Phadiatop, IgE ≥0.35kU/L 
4. In addition to 3: at least one positive test to a specific aeroallergen (IgE≥0.35 k/UL) 
 
7.1.2.2  Misclassification 
Information bias rises from systematic errors in the measurement and classification of 
exposures and outcomes. If the misclassification of a variable is dependent on another 
variable the misclassification is said to be differential. A protective factor misclassified to be 
more common among the group with the outcome would lead to underestimation of the 
association. Moreover, a protective factor misclassified to be more common among the group 
without the outcome would lead to overestimation of the association. The same is true for 
differential misclassification of the outcome. Any misclassification not dependent on another 
factor is called non-differential and will only dilute the true association.  
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Misclassification of exposure  
In the present studies, differential misclassification of exposure should be prevented by the 
longitudinal design; exposure data was collected before the outcome has occurred. Non-
differential misclassification is possible, however. 
 
Body mass index (BMI) was used as the exposure in study I. Weight and height measured 
by trained nurses during routine controls were registered at child and school care centers. The 
classification of normal vs. high BMI was based on the 85
th
 percentile of BMI in the study 
population, taking age and gender into account, this step should not introduce any 
misclassification. Reference values to discriminate normal from high BMI are available; all 
take sex and age into account, but are based on different populations and cover different age 
spans. BMI discriminates subjects with a high weight for height, and it is debated how good 
of a measure BMI is at identifying adiposity. However, BMI has been shown to identify 
overweight in children to a high extent.
49, 50
 In any case, BMI is not a good measure of fat 
mass distribution; to study that we need other measures. 
 
Infant fish consumption was used as the exposure in study II. The frequency of fish 
consumption was asked for in the 1-year follow-up. Recent intake was reported, meaning that 
information bias should be a minor problem.  
 
Fish consumption in childhood was used as the exposure in study III. All dietary 
measurement methods have inherent problems in capturing people’s true intake. Here, I will 
discuss problems with food frequency questionnaires (FFQs) related to the measurement and 
classification of fish intake. Compared with persons with a regular fish intake, subjects who 
eat fish irregularly might find it harder to remember how often they have actually consumed 
fish in the past year and which types of fish were consumed, meaning that their exposure 
might be misclassified to a higher degree. Some types of fish are consumed seldom by most 
people and therefore easy to forget about when filling out a FFQ. However, the quantities can 
be large when these fish are consumed. An example is herring, which is usually eaten during 
our traditional festivals: Easter, Midsummer, and Christmas. Such irregular intake might not 
contribute much to the total amount of fish and might have a limited biological effect on the 
outcome. Eight-year-old children in Sweden are served school lunch and should be served 
fish at least once per week. Out of all children in the cohort, 83% report a fish intake of at 
least one time per week. Children might have trouble distinguishing between types of fish 
served in school. All these potential problems could have led to misclassification of fish 
intake. Nevertheless, any misclassification is most probable of the non-differential type, 
which leads to a dilution of a true association.  
 
Consumption of polyunsaturated fatty acids (PUFAs) in childhood was used as exposure 
in study III. The estimated intakes of different PUFAs were calculated from the FFQ. In 
addition to the above discussion of problems connected to reporting of food intake in FFQs, 
additional potential problems concerns the nutrition calculation. Exact portion sizes of fish 
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intake were not asked about in the FFQ, instead portion sizes obtained from the Swedish 
national study Riksmaten 2003 were used. These might differ from the true portion sizes on 
an individual level but are hopefully representative on a group level, since Riksmaten 2003 
includes the same age group that answering the FFQ in BAMSE. An additional potential 
problem can be to find nutrient composition values in the nutrient database which correspond 
to the reported food, and the nutrient values in the database might not be exact, since many 
factors affect nutrient content in for example fish (such as the way of farming and preparation 
methods). We compared the calculated intake levels of PUFAs with blood proportions of the 
same PUFAs, the correlation varied from 0.02 for linoleic acid (LA, 18:2 n-6) to 0.29 for 
docosahexaeonic acid (DHA, 22:6 n-3). The correlation for total very long-chain (VLC) n-3 
fatty acids was 0.23, and 0.24 with reported oily fish intake. These moderate correlations can 
indicate poor assessment of PUFAs through the FFQ. On the other hand, blood proportions of 
PUFAs are affected by more than dietary intake and the measurement also has its limitations 
(see discussion below). The calculated consumption of PUFAs in BAMSE is slightly higher 
than was reported in Riksmaten 2003,
133
 probably due to the different dietary assessment 
methods used. In study III, the calculated intake of different PUFAs was divided into tertiles. 
In that way, we could minimize the problem that we might not capture the absolute intake.  
 
Plasma proportions of PUFAs were used as exposures in study IV. By using plasma to 
measure PUFAs, we could avoid the potential problems with dietary assessment methods. 
However, measurement in plasma can also be affected by a number of different factors. The 
blood sampling took place at the clinical examination at age 8 years; all those who attended 
were asked to provide a blood sample. Potential sampling variability should be random. 
Other factors that can possibly affect the plasma samples are storage, batch effects and 
laboratory measurement errors. These factors should affect samples from children with 
allergic disease the same as samples from children without allergic disease and therefore only 
introduce non-differential misclassification. Samples from children with allergic disease are 
more likely to have been thawed over the years compared with samples from children without 
allergic disease. Therefore, a higher degradation of PUFA can have taken place in samples 
from children with allergic disease. The observed inverse association between increasing 
PUFA proportions and a reduced risk of allergic disease might therefore be incorrect. In any 
case, the results of incidence of disease cannot be affected. 
 
Disease-related misclassification of exposure 
Even if studies I-IV are longitudinal and differential misclassification of exposure should be 
impossible, since the outcome under study had not happened when the exposure was 
assessed; disease-related modification of exposure could still be a problem. Parental allergic 
disease and early symptoms of allergic disease may affect which foods the children are 
served and may also affect overweight status; therefore, a possible impact of disease-related 
modification of exposure needs to be assessed in studies of allergic disease. This was done in 
all studies; by restriction or adjustment. In studies I and II we restricted analyses to children 
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without early symptoms of disease. This attenuated the observed ORs for the association 
between early high BMI and asthma at age 8 years in study I, and for the associations 
between early fish intake and asthma, and eczema in study II. Additional adjustment had 
minor impact on the observed associations in studies I, III and IV. 
 
Misclassification of outcome 
Some subjects will confuse colds with rhinitis symptoms, and wheeze can be due to airway 
infections. We used strict definitions to avoid misclassification. Information bias might be a 
problem; some perceive symptoms better while others do not remember them. Parents with 
allergic disease themselves might be more aware of symptoms in their children. Any 
misclassification is not likely to be related to the exposures under study in this thesis and is 
probably non-differential. In addition, we used immunoglobulin E (IgE) levels measured in 
blood samples as an objective marker to distinguish between IgE-associated and non-IgE-
associated disease. 
7.1.2.3 Confounding 
Confounding is described in section 4.5.3. Uncontrolled confounding can lead to observation 
of associations that in reality are due to a confounding factor. Uncontrolled confounding can 
also mask true associations. Due to the extensive questionnaires we were able to test a range 
of potential confounders in each study. The factors were chosen based on a priori knowledge, 
and then their impact on the association between exposure and outcome was tested. Few 
factors changed the crude OR in my studies, the ones that did were adjusted for in a 
multivariable model. Despite the broad range of factors tested, residual confounding can still 
be present, due to either unmeasured confounding or measurement errors in measured 
confounders. 
 
7.1.3 Generalizability  
Based on the minor differences between the original cohort and the non-participants and 
between the different study populations and the original cohort (discussed in greater detail in 
section 7.1.2.1) the generalizability of the results to a Swedish population of children is good. 
The associations we have observed should be generalizable to most populations, given the 
belief that the underlying biological mechanisms are the same. Selection bias may have a 
greater influence if we want to compare prevalence rates. However, regarding study I, we 
should be cautious to generalize the observed results to an obese population (see section 4.2.3 
for more information).  
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7.2 MAIN FINDINGS AND INTERPRETATIONS 
7.2.1 Body mass index in relation to asthma and allergic sensitization at age 
8 years 
In study I we observed that children with a high BMI (≥the 85th percentile) during early 
childhood, but whose BMI normalized before age 7 years, had no increased risk of asthma. In 
contrast, children with a high BMI at age 7 years had an increased risk of asthma at age 8 
years, regardless of their earlier BMI status. Moreover, a high BMI at age 7 years was 
associated with an increased risk of aeroallergen sensitization at age 8 years.  
 
At the time of study I a number of longitudinal studies suggested high BMI to precede 
asthma in childhood.
73-78
 However, to my knowledge, change in BMI status from early 
childhood had only been investigated in one previous study of 3,756 children from a Dutch 
birth cohort, in which they observed that early-transient high BMI was not associated with 
subsequent asthma, while a current high BMI was.
79
 The results from study I were in line 
with the findings from the Dutch study. More recent longitudinal studies have shown 
contradictory results; some report that high BMI seems to precede asthma,
139
  including a 
Mendelian randomization study,
140
 while others have observed a bidirectional association.
141, 
142
  
 
A few studies have tried to disentangle if the timing of growth is of importance for asthma 
risk. A study using data from eight European birth cohorts observed that a rapid increase in 
BMI during the first 2 years of life was associated with an increased risk of incident asthma 
up to age 6 years.
143
 There was also a tendency of an association for children with a persistent 
rapid growth up to age 6 years, however, there was less power to draw any conclusions from 
this group. In this same manner, a study of 9,723 children from an English birth cohort 
observed an increased risk of asthma up to age 17 years for children with a rapid weight 
growth during the first 3 months of age.
144
 In contrast, a study based on a birth cohort from 
the United Kingdom, including 1,456 children, reported that early persistent and delayed high 
BMI was associated with asthma at age 18 years, while no association was observed for 
early-transient high BMI.
145
 
   
Several meta-analyses of the association between overweight and asthma have been 
published. A recent review summarized meta-analyses and concluded that the current 
evidence suggest a mild-to-moderate causal effect of childhood overweight on asthma risk.
22
 
However, the included meta-analyses are published 2006 and 2013. Thus, the more recent 
studies are not included. Despite several longitudinal prospective studies which have 
investigated the association between overweight, mainly using BMI as a proxy, and asthma in 
childhood, there is still no clear picture of the temporal relation.
139-142
 To come closer to the 
temporal relation it is important to disentangle the timing of onset of overweight contra onset 
of asthma; this is hard and needs to be further investigated. 
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There are few longitudinal studies of overweight and allergic sensitization. We revealed a 
significant association between a high BMI at school age and higher prevalence of 
aeroallergen sensitization at age 8 years in study I. This was not in line with two previous 
studies, which reported no association.
78, 79
 In contrast, a recent study of 414 children who 
were followed for 2 years confirmed our findings.
146
 Incident allergic sensitization was 
associated with an increase in BMI during the same period. Unfortunately, they did not 
distinguish between different types of sensitization.  
 
A potential association between BMI and asthma and allergic sensitization is biologically 
plausible and most likely multifactorial. A number of review articles have discussed different 
possible mechanisms linking BMI with asthma in particular.
59, 147, 148
 These include effects on 
lung function, upgraded inflammation through leptin, and behavioral factors. Despite several 
potential mechanisms suggested, the causal link is still unclear. Mutual risk factors have also 
been suggested, for example prenatal factors and genetic predisposition.
61, 149
 The significant 
associations observed in study I between a high BMI and asthma and aeroallergen 
sensitization at school age, but not between early-transient high BMI and the outcomes, 
support the hypothesis that the two diseases share risk factors.  
 
7.2.2 Fish consumption in relation to allergic disease 
We observed that regular fish intake in infancy (≥2-3 times/month) reduced the risk of 
asthma, rhinitis and eczema up to age 12 years (study II). However, the inverse associations 
for asthma and eczema weakened after restriction to children without early symptoms of 
allergic disease, but the association for rhinitis was not affected. In addition, regular oily fish 
consumption at age 8 years (≥1 time/week) was associated with a reduced risk of developing 
rhinitis between ages 8 and 16 years, also after adjustment for early fish intake and early 
symptoms of allergic disease (study III).  
 
At the time of study II, several longitudinal studies had investigated the role of fish intake in 
infancy in relation to allergic disease up to age 4 years. The majority observed an inverse 
association between early introduction or frequent intake of fish in infancy and subsequent 
allergic disease (asthma, rhinitis, eczema, or allergic sensitization) during preschool age,
95, 97-
102
 including a previous report from BAMSE.
96
 In this same manner, two other longitudinal 
studies reported an increased risk of wheeze at age 3 years and aeroallergen sensitization at 
age 5 years among children with delayed introduction of fish.
150, 151
 One prospective study 
based on a Dutch birth cohort reported no association between fish consumption at age 2 
years and asthma or wheeze at age 3 years.
152
 To my knowledge, two other studies have 
investigated the association of infant fish intake with allergic disease beyond pre-school 
age.
118, 153
 In one of the studies, based on 4,051 children from a Swedish birth cohort, 
introduction of fish before 9 months of age was observed to reduce the risk of prevalent 
asthma at age 8 years.
153
 In contrast, the other study including 3,269 children from a Dutch 
birth cohort, reported no association between fish intake at age 2 years and prevalent asthma 
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at age 8 years.
118
 The discrepancies can be due to the amount of different fish species 
consumed, the definition of outcome, or the timing of exposure and outcome. Most of these 
studies took parental allergic disease and early symptoms of allergic disease into account by 
adjustment or restriction, which is of importance since disease-related modification of 
exposure can affect introduction and consumption of fish in early life. Parents with allergic 
disease, or who see signs of early symptoms in the children, might delay the introduction of 
fish to their infant’s diet. When the children in BAMSE were newborns the recommendation 
was to delay introduction of fish for infants at increased risk of allergic disease.
37
 We could 
see that parental allergic disease and early symptoms of allergic disease delayed the 
introduction and reduced the amount of fish in the child’s diet at age 1 year, which has also 
been reported previously in a study from BAMSE.
96
 We handled this by adjusting all 
analyses for parental allergic disease and in a second step we restricted the analyses to 
children without early symptoms of allergic disease. The inverse associations for asthma, and 
eczema weakened after restriction, but the association for rhinitis was not affected. The 
recommendation to delay the introduction of allergenic foods has since been removed.
38
 
 
Fish consumption in infancy seems to be a window of opportunity to influence the risk of 
allergic disease, maybe through the content of immuno-modulatory factors in oily fish, for 
example vitamin D or VLC n-3 fatty acids (possible mechanisms are discussed below). At the 
same time, the impact of fish intake in infancy is difficult to disentangle from a possible 
influence of maternal intake during pregnancy on the risk of childhood allergic disease.
33, 154
 
We could unfortunately not adjust for maternal fish intake during pregnancy in study II due 
to lack of information. Therefore, our finding of an association between regular infant fish 
intake and subsequent allergic disease might be due to a high exposure of fish in utero. 
Studies that could take consumption during pregnancy into account have observed 
independent associations for infant intake.
100, 151
  
 
Fish consumption later in childhood can also play a role for the risk of childhood allergic 
disease, since the occurrence and incidence is high up into adolescence.
3, 155
 Intake of fish at 
school age has been associated with a reduced risk of asthma and allergic sensitization in 
cross-sectional studies,
103-112
 with some exceptions.
113-117
 However, inverse associations have 
not been observed for rhinitis.
104, 107, 113, 115, 116
 We did not observe an association between fish 
intake at age 8 years and rhinitis at the same age in study III. In longitudinal analyses, we 
found a reduced risk of incident rhinitis between ages 8 and 16 years for children with regular 
intake of oily fish. Study III was the first longitudinal study that investigated the association 
between fish consumption and risk of developing rhinitis all the way up to adolescence; our 
findings need to be confirmed or refuted in future longitudinal studies. The result from study 
III was not affected by infant fish intake and could not be explained by disease-related 
modification of exposure. 
 
One explanation for the observed association between intake of oily fish and allergic disease 
could be that fish is part of a healthy lifestyle in general, which in itself lowers the risk of 
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allergic disease. We tried to adjust our analyses for a number of lifestyle factors, for example 
other dietary factors, like fruit, vegetable, and meat consumption. None of the other dietary 
factors could explain the inverse association between oily fish and development of rhinitis.  
 
The mean intake of fish in the study population was in line with the intake reported in the 
Swedish national report Riksmaten 2003 for the same age group (1.70 vs. 1.75 times per 
week).
133
 An intake of oily fish once per week or more, which was associated with a reduced 
risk of allergic disease, is in line with the current dietary guidelines to consume different 
types of fish at least twice a week.
85
  
 
An inverse association between oily fish and allergic disease, including rhinitis, is 
biologically possible and might be explained by the rich amount of vitamin D in oily fish. 
Vitamin D has immuno-modulatory properties.
90
 We did not observe an association between 
intake of vitamin D at age 8 years and incident rhinitis between ages 8 and 16 years in study 
III. Vitamin D intake is low in general, including among our study participants, and the status 
of vitamin D is therefore highly determined by sun exposure.
90
 Blood levels of vitamin D are 
widely used instead of intake data, but unfortunately these levels have not been measured in 
BAMSE. A recent review of observational studies concluded that the evidence for an 
association between serum vitamin D and allergic disease in childhood is lacking, but added 
that vitamin D seems to reduce the severity of asthma.
156
   
 
Other constituents of oily fish which might explain the reduced risk of allergic disease are the 
VLC n-3 fatty acids EPA, DPA, and DHA. These are discussed in the next section. 
Regardless of what components in fish that exert the influence on allergic disease we 
observed infant fish consumption to reduce the risk of rhinitis, in particular, up to age 12 
years (study II) and fish intake at school age to reduce the risk of incident rhinitis between 
ages 8 and 16 years (study III).    
   
7.2.3 Polyunsaturated fatty acids in relation to allergic disease 
In study III we reported that a higher intake of total VLC n-3 fatty acids at age 8 years was 
associated with a reduced risk of developing rhinitis between ages 8 and 16 years, in 
particular non-IgE-associated rhinitis. Furthermore, we found inverse associations between 
increased plasma proportions of total VLC n-3 fatty acids at age 8 years and asthma, rhinitis 
and aeroallergen sensitization at ages 8 and 16 years in study IV. Increased plasma 
proportion of total VLC n-3 fatty acids was also associated with a reduced risk of incident 
asthma between ages 8 and 16 years. Increasing plasma proportions of AA was inversely 
associated with asthma and aeroallergen sensitization at ages 8 and 16 years. The inverse 
associations between plasma proportions of total VLC n-3 fatty acids and AA and allergic 
disease were most pronounced for the IgE-associated phenotypes.   
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Previous studies of dietary PUFA and allergic disease in childhood have been cross-sectional. 
Studies of intake of total PUFA have reported no association for rhinitis,
129, 157
 but have 
observed an increased risk of wheeze or asthma among children with higher intake of 
PUFA.
127, 128, 157, 158
 The results from analyses of consumption of specific n-3 and n-6 fatty 
acids have been inconclusive. No significant associations have been reported between VLC 
n-3 fatty acid intake and asthma or rhinitis.
117, 127-129
 A Japanese survey, based on around 
25,000 children between ages 6 and 15 years, observed an association between higher intake 
of LA and increased risk of wheeze,
127
 and an inverse association between increasing AA 
intake and rhinitis at school-age.
129
 For comparison, I performed cross-sectional analyses for 
study III and observed significant associations between the highest tertile of total PUFA and 
ALA consumption and an increased risk to have non-IgE-associated rhinitis at age 8 years. 
 
In contrast to dietary PUFAs, increased proportions of total VLC n-3 fatty acids in plasma at 
age 8 years was inversely associated with rhinitis, asthma, and aeroallergen sensitization at 
the same age in study IV. This finding was in line with previous cross-sectional studies of 
blood composition, which reported lower blood proportions of VLC n-3 fatty acids in allergic 
subjects than in controls.
104, 130, 131
 However, some did not observe any differences for VLC 
n-3 fatty acids.
112, 159
 In one recent international study of 2,400 children, associations between 
total n-6 fatty acids, and DPA and increased risk of current allergy in children aged 2-9.9 
years were observed.
160
 In age stratified analyses the associations were confined to the 
youngest age group (2-3.9 years). Our finding of inverse associations between AA and 
allergic disease at age 8 years is not supported by previous studies; no differences in LA and 
AA proportions between allergic cases and controls have been observed.
104, 112, 131, 159, 161
 One 
Korean study observed increased levels of AA in allergic children.
130
 
 
Increased plasma proportions of total VLC n-3 fatty acids at age 8 years was observed to 
reduce the risk of asthma, rhinitis, and allergic sensitization at age 16 years, as well as the risk 
of incident asthma between ages 8 and 16 years, in study IV. A recent study from Finland 
reported a similar inverse association between higher proportions of EPA, DHA and total 
VLC n-3 fatty acids in serum during preschool age and a reduced risk of developing asthma 
up to age 5 years.
162
 However, additional adjustment for cow’s milk allergy attenuated the 
findings and only the association for EPA remained significant. Disease-related modification 
of exposure did not have the same influence on the associations in our study; adjustment for 
symptoms of cow’s milk allergy up to age 8 years and adjustment for early symptoms of 
allergic disease did not affect the observed associations in study IV. We observed the most 
pronounced findings for the IgE-associated phenotypes of allergic disease in study IV. In 
contrast, the significant association for EPA was most apparent for the non-IgE-associated 
phenotype of asthma in the Finish study. An explanation for the differences can be the older 
age of the children in our study. Disease-related modification of exposure might have a 
smaller influence in older children and allergic sensitization increase with increasing age.
163
 
The inverse association between a higher proportion of AA and allergic disease observed in 
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study IV was not found in the Finnish study. To my knowledge, there are no other published 
studies on blood proportions at school-age and development of allergic disease.  
 
An inverse association between VLC n-3 fatty acids and allergic disease is biologically 
plausible. VLC n-3 fatty acids have been demonstrated to have a range of anti-inflammatory 
effects; they seem to lower the production of inflammatory mediators and increase the level 
of anti-inflammatory mediators.
123
 The n-6 fatty acid AA has been shown to have both pro- 
and anti-inflammatory effects, for example through the prostaglandins (PGs) D2 and E2.
7
 Both 
PGD2 and PGE2 have been labeled as pro-inflammatory, but in the respiratory system PGE2 
seems to have beneficial effects, such as protection against bronchoconstriction and inhibited 
recruitment of inflammatory cells. Therefore, our finding of an inverse association between 
higher proportions of AA in plasma phospholipids and allergic disease is plausible. We could 
not observe the same finding for dietary intake of AA, but this might be due to the low 
consumption of AA in our study population. 
 
In summary, both the calculated dietary intake and plasma proportions of total VLC n-3 fatty 
acids were associated with a reduced risk of subsequent allergic disease (studies III and IV). 
In addition, we observed plasma proportions of AA to be associated with a reduced risk of 
allergic disease in study IV. 
 
7.2.4 The relation between calculated intake and plasma proportions of 
polyunsaturated fatty acids 
The correlations between the different PUFAs, as calculated intakes from the FFQ filled out 
at age 8 years and as proportions measured in plasma phospholipids from the same age, were 
moderate. LA, ALA and VLC n-3 fatty acids are considered to be good biomarkers of dietary 
intake, since LA and ALA are essential fatty acids not endogenously produced in the human 
body and the conversion rate of VLC n-3 fatty acids is low in most humans.
121
 One 
explanation for the moderate correlations observed in study IV may be that the long-term 
storage of the plasma samples has led to degradation of the fatty acids. However, the samples 
were stored in minus 80ºC, a temperature at which the fatty acid composition should be stable 
over time.
136
 Another possible explanation is that the FFQ and plasma phospholipid fraction 
correspond to slightly different time spans. In the FFQ the intakes over the previous 12 
months were asked for, while plasma phospholipids reflect more recent intake.
136
 In addition, 
fatty acids are affected by absorption and metabolism and therefore classified as 
concentration biomarkers, meaning that correlation coefficients between them and estimated 
dietary intake will be substantially lower than one, regardless of perfect assessment of dietary 
intake.
164
 Validation studies in adults have reported correlation coefficients between 0.20-
0.60 for the different VLC n-3 fatty acids calculated from FFQ and measured in blood.
165
 The 
correlation coefficients reported from validation studies in children have been in the lower 
range (0.20-0.30).
166-168
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8 CONCLUSIONS  
In the studies included in this thesis we found that: 
 High body mass index during the first 4 years of life was not associated with risk of 
asthma during school age among children who had developed a normal weight by 7 
years of age. (Study I) 
 
 High body mass index at age 7 years was associated with an increased risk of asthma 
and aeroallergen sensitization at school age. (Study I) 
 
 Fish intake may reduce the risk of subsequent allergic disease. (Studies II and III)  
More specifically: 
A regular fish consumption in infancy seemed to reduce the risk of rhinitis during 
childhood, also after adjustment for fish intake at school age. Early symptoms of 
allergic disease attenuated the inverse associations for asthma and eczema. (Study II) 
A regular intake of oily fish at school age seemed to reduce the risk of developing 
rhinitis in adolescence. (Study III) 
 
 Polyunsaturated fatty acids in childhood appeared to influence the risk of allergic 
disease in adolescence. (Studies III and IV)    
More specifically:  
A high proportion of VLC n-3 fatty acids, in diet and plasma, seemed to reduce the 
risk of subsequent allergic disease. (Studies III and IV) 
A high proportion of AA in plasma seemed to reduce the risk of subsequent allergic 
disease. (Study IV)   
 
Overall, these studies indicate that body mass index is associated with concurrent asthma and 
aeroallergen sensitization at school age. Moreover, consumption of fish, both in infancy and 
childhood, and polyunsaturated fatty acids, especially VLC n-3 fatty acids, appear to be 
associated with a reduced risk of subsequent allergic disease throughout childhood.  
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9 FUTURE PERSPECTIVES 
Results from the studies included in this thesis have added to previous knowledge from 
epidemiological research. In epidemiology, a single study may indicate an association, but the 
accumulated knowledge from multiple studies can help us draw conclusions about 
associations between exposures and outcomes. 
   
A great number of studies have tried to disentangle the association between overweight and 
asthma during childhood. However, few studies assessed both body mass index (BMI) and 
asthma at several time points from infancy to adolescence which is needed to come closer to 
the temporal relationship. To be able to investigate all the different trajectories of overweight 
and asthma with enough power, international collaborations are probably needed.  
 
Most of the previous studies have like us used BMI as a proxy of overweight. To further 
understand the mechanisms behind an association between overweight and asthma, 
longitudinal studies with more precise measures of adiposity distribution and fat mass are 
needed. Moreover, the association between overweight and allergic sensitization need to be 
further investigated. Our finding of an association between a high BMI and aeroallergen 
sensitization at school age need to be replicated or refuted, preferably in studies of incident 
sensitization.   
 
Despite an increasing number of studies on timing of introduction of food and allergic 
disease, there are few longitudinal studies of fish or polyunsaturated fatty acid (PUFA) intake 
in childhood and subsequent risk of allergic disease up to adolescence. Therefore, our 
observed associations between consumption of oily fish and PUFAs in childhood and a 
reduced risk of incident allergic disease up to age 16 years need to be replicated or refuted in 
other cohort studies. Future studies of fish and PUFAs should strive to separate the analyses 
for the different types of fish and PUFAs, as we have done, since the associations and 
biological mechanisms probably differ. To be able to study specific intake, diet needs to be 
assessed through a detailed questionnaire, and to further enhance the exposure assessment, a 
combination with biomarkers of intake would be preferred. 
 
Fish and PUFAs are not consumed in isolation, but make up part of an overall diet. 
Synergistic effects and diet-gene interactions possibly occur and need to be considered in 
future research. Another aspect of diet is food choice. Subjects with high intake of fish, for 
example, must consume less of something else. It would be interesting to investigate if the 
strength of the association with allergic disease differs depending on what food items subjects 
with high fish intake consume less of. And in addition, to investigate if the association 
between a high fish intake and a reduced risk of allergic disease differs depending on what 
the subjects in the reference group with a low fish intake consume instead.  
 
Finally, I hope that the findings in this thesis will contribute to the knowledge about 
modifiable factors for the risk of allergic disease in children, and inspire new research within 
the area that in the end can lead to suggestions to families and society on how to prevent 
allergic disease. 
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